Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,motor activity (GO:0003774),0.89390524264753,2.0464831917160935,0.0,0.0,0.0,14/60,1.09%,KIF11;KIF18B;KIF15;KIF20B;KIF4A;CENPE;KIF14;KIF23;KIF2C;KIF24;KIFC1;KIF18A;KIF20A;KIF22
prerank,microtubule motor activity (GO:0003777),0.9080194821886608,2.0463843448166075,0.0,0.0,0.0,14/51,1.09%,KIF11;KIF18B;KIF15;KIF20B;KIF4A;CENPE;KIF14;KIF23;KIF2C;KIF24;KIFC1;KIF18A;KIF20A;KIF22
prerank,single-stranded DNA helicase activity (GO:0017116),0.9058687482333696,1.8873483115489473,0.0,0.03635636095141637,0.105,13/19,6.49%,POLQ;PIF1;RAD51;MCM5;DSCC1;RFC4;MCM6;MCM7;MCM2;DNA2;DHX9;RFC2;RFC3
prerank,microtubule binding (GO:0008017),0.7853835703159094,1.877215025997013,0.0,0.03861045533040418,0.144,48/222,5.68%,PRC1;KIF18B;TPX2;KIF15;KIF20B;CENPE;KIF14;KIF23;KIF2C;NUSAP1;DLGAP5;KIFC1;SKA1;PLK1;BIRC5;FAM83D;SPAG5;RACGAP1;KNSTRN;GTSE1;KIF18A;CEP295;KIF20A;KIF22;CDK5RAP2;CKAP5;GAS2L3;VASH2;SKA2;HAUS8;TERF1;CEP57;MAST2;PSRC1;MAP4K4;CCDC61;HAUS4;HAUS6;MACF1;FAM161A;KIF27;TUBGCP5;SPEF1;CEP57L1;NUMA1;PRNP;MAPT;HAUS7
prerank,single-stranded DNA binding (GO:0003697),0.7780529975942595,1.843153169946591,0.0,0.08516113989259769,0.343,34/93,7.38%,NEIL3;RAD51AP1;RAD51B;RAD51;MCM5;POLA1;DDX11;RAD51AP2;HMGB2;BRCA2;MCM8;CDC45;DMC1;SMC6;FAM111A;MCM10;MCM6;MCM7;MCM2;RBBP8;RPA1;STN1;MSH3;ERCC4;TDP2;DHX9;HNRNPA1;BLM;MAPT;MCM3;RPA2;MCM4;MLH1;NUCKS1
prerank,DNA replication origin binding (GO:0003688),0.8758858106930882,1.8348197810044988,0.0,0.09060005149092958,0.409,16/23,7.66%,MCM5;POLA1;ORC1;DDX11;MCM8;CDC45;MCM10;MCM6;MCM7;MCM2;CDC6;DHX9;MCM3;MCM4;ORC2;ORC3
prerank,DNA secondary structure binding (GO:0000217),0.8224688428660785,1.8323532054069125,0.0011961722488038277,0.0826432022084196,0.429,16/31,9.85%,NEIL3;RAD51AP1;CLSPN;RAD51B;GEN1;RAD18;HMGB2;XRCC2;RBBP8;LIN54;BLM;MAPT;RAD51C;HMGB3;HMGB1;KMT2A
prerank,kinesin binding (GO:0019894),0.8323072896235885,1.819665862874402,0.0,0.10077983255732617,0.537,3/27,0.71%,PRC1;KIF18B;FAM83D
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.8479483476594273,1.7939823056342294,0.009102730819245773,0.15647777753489603,0.72,8/21,5.94%,POLK;POLQ;POLE;POLA1;POLH;PRIMPOL;POLD3;POLD1
prerank,DNA polymerase activity (GO:0034061),0.8411586082572118,1.7880126072721103,0.009079118028534372,0.15967713729862068,0.762,8/22,5.94%,POLK;POLQ;POLE;POLA1;POLH;PRIMPOL;POLD3;POLD1
prerank,ligand-gated anion channel activity (GO:0099095),-0.6114418643337285,-1.7728017500682893,0.008,1.0,0.494,11/17,15.05%,GABRB1;GABRB3;GABRA2;GLRB;GLRA1;GABRA3;GLRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.7781601528242331,1.7704573639220014,0.0034403669724770644,0.20282883262422904,0.857,10/42,6.38%,CCNF;CCNB1;CCNE2;CKS2;CCNB2;CDKN2D;CDKN2C;CCNA2;CCNA1;CCNE1
prerank,GABA-A receptor activity (GO:0004890),-0.5886092986937905,-1.7589475896507234,0.0,0.6880790785434678,0.541,8/18,15.05%,GABRB1;GABRB3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,"DNA binding, bending (GO:0008301)",0.878115196722393,1.7561851974099543,0.011412268188302425,0.24067910949837634,0.908,3/14,1.68%,TOP2A;HMGB2;TERF1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5204485279163097,-1.752569780457795,0.0,0.48558581392510813,0.562,10/26,15.78%,SLC6A6;SLC16A12;SLC6A1;MPC1;SLC27A1;ABCG2;SLC5A6;SLC16A1;SLC16A4;SLC6A11
prerank,tubulin binding (GO:0015631),0.7360691816689421,1.751578982208758,0.0,0.24069029607097675,0.931,39/295,2.52%,PRC1;KIF18B;TPX2;KIF15;KIF20B;CENPE;KIF14;BRCA1;KIF23;KIF2C;NUSAP1;DLGAP5;KIFC1;SKA1;PLK1;BIRC5;FAM83D;SPAG5;RACGAP1;GTSE1;KIF18A;CEP295;KIF20A;KIF22;CDK5RAP2;CKAP5;GAS2L3;VASH2;BRCA2;SKA2;HAUS8;TERF1;CEP57;STMN1;MAST2;PSRC1;MAP4K4;CCDC61;HAUS6
prerank,damaged DNA binding (GO:0003684),0.7538778648385187,1.7494841632093217,0.004454342984409799,0.23072785412938868,0.934,18/44,11.90%,NEIL3;POLQ;RAD18;HMGB2;AUNIP;SMC6;RBBP8;RPA1;ERCC4;RAD1;POLD1;RPA2;ERCC3;CUL4B;HMGB1;XPA;PCNA;FANCG
prerank,3'-5' DNA helicase activity (GO:0043138),0.8684898876811367,1.7444966624782932,0.008310249307479225,0.23279705044410928,0.952,9/16,6.10%,NAV2;MCM5;MCM6;MCM7;MCM2;DHX9;BLM;RECQL;ERCC3
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.8944479292985212,1.736582944787781,0.005891016200294551,0.24709600720630134,0.966,4/13,4.70%,EXO1;ZGRF1;GEN1;DNA2
prerank,glycine binding (GO:0016594),-0.6740380864869876,-1.7215858661789916,0.012461059190031152,0.4895660255146583,0.662,6/11,14.10%,GRIN3A;GLRB;GLRA1;GRIN2B;GLRA3;GRIN1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.8758810337149424,1.7140466252875532,0.011764705882352941,0.3216639728223902,0.991,2/11,3.97%,NEIL3;APEX2
prerank,MHC class II protein complex binding (GO:0023026),-0.6823427853994453,-1.713902101005589,0.01524390243902439,0.41732518516432454,0.687,5/11,10.73%,HSP90AB1;ATP1B1;ANXA11;PKM;CD81
prerank,endodeoxyribonuclease activity (GO:0004520),0.8010120533233658,1.7001511124295265,0.0215633423180593,0.3663751680944065,0.997,6/20,5.32%,EXO1;ZRANB3;RBBP8;ERCC4;DNA2;MRE11
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.5176086705821434,-1.699946831610786,0.010752688172043012,0.39976250152543485,0.744,15/27,17.84%,PRKN;DCUN1D3;RNF180;RNF144B;ZMYM2;RNF19B;DCUN1D5;SIAH1;DCUN1D4;RNF217;ARIH2;RNF125;DCUN1D2;UBE3D;AUP1
prerank,amino acid binding (GO:0016597),-0.4713064229762321,-1.69265934474425,0.012048192771084338,0.36845387286120623,0.771,8/31,7.45%,GRM7;GRIN3A;GLRB;GLRA1;GRIN2B;NOS3;GLRA3;AARS1
prerank,anion channel activity (GO:0005253),-0.4085108101737113,-1.687725624195883,0.0,0.33527063561350645,0.791,21/61,15.73%,GABRB1;ANO3;GABRB3;GABRA2;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;CLCN7;GPR89B;GPR89A;GABRA5;GABRB2;ANO4;GABRG2;LRRC8B;LRRC8D;GABRG1;TTYH3
prerank,microtubule plus-end binding (GO:0051010),0.8042706763907697,1.6867726487193366,0.02577319587628866,0.4065176932319213,0.999,4/20,4.92%,KIF2C;KNSTRN;KIF18A;NUMA1
prerank,ATP hydrolysis activity (GO:0140603),0.7500836618221638,1.6657430429989533,0.006825938566552901,0.48841135302132743,1.0,6/41,4.75%,KIF20B;KIF14;ABCA4;CHD1L;DNA2;DHX9
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.47334715038968367,-1.6631394185947688,0.0,0.3636918339951374,0.848,17/33,20.05%,PRKN;DCUN1D3;RNF180;RNF144B;ZMYM2;RNF19B;DCUN1D5;SIAH1;DCUN1D4;RNF217;ARIH2;RNF125;DCUN1D2;UBE3D;AUP1;TCERG1;PARK7
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5843233367862912,-1.6630679891606575,0.003257328990228013,0.3273226505956236,0.848,9/15,15.37%,HS3ST4;HS3ST1;HS6ST3;NDST3;NDST1;HS3ST3B1;HS3ST3A1;NDST2;NDST4
prerank,methylation-dependent protein binding (GO:0140034),0.721373256279733,1.659843197483943,0.009857612267250822,0.49656556540614505,1.0,14/57,8.81%,UHRF1;PHF19;NCAPG2;ATRX;NCAPD3;CBX5;SGF29;SUZ12;MPHOSPH8;FMR1;PHF2;PHF1;ING4;MSL3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.8043567890073895,1.646269885147954,0.04217687074829932,0.5459403365413595,1.0,1/16,0.14%,NEIL3
prerank,glutamate receptor binding (GO:0035254),-0.5773621994503698,-1.6448569295076556,0.023255813953488372,0.3465497863537797,0.89,9/17,14.03%,SHANK3;SYNDIG1;IGSF11;HOMER1;SQSTM1;SHISA6;SHANK1;DLG4;HIP1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.8510024219313943,1.6354309782156777,0.049204052098408106,0.5822961226886503,1.0,3/10,5.94%,EXO1;MGME1;POLD1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6319202241536732,-1.6307865901260084,0.025974025974025976,0.35859218789602637,0.919,8/12,15.05%,GABRB1;GABRB3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,methylated histone binding (GO:0035064),0.7039498079040475,1.6266266005961423,0.010822510822510822,0.6039882244858801,1.0,14/62,8.81%,UHRF1;PHF19;NCAPG2;ATRX;NCAPD3;CBX5;SGF29;SUZ12;MPHOSPH8;FMR1;PHF2;PHF1;ING4;MSL3
prerank,ligand-gated channel activity (GO:0022834),-0.4784582231378279,-1.6239334747910632,0.023809523809523808,0.3488043117996088,0.926,8/29,6.05%,GRIK1;GRIN3A;GABRB1;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4
prerank,ligand-gated ion channel activity (GO:0015276),-0.4766537220620686,-1.604819537928407,0.025477707006369428,0.3767696720750876,0.956,8/30,6.05%,GRIK1;GRIN3A;GABRB1;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4
prerank,histone acetyltransferase binding (GO:0035035),0.750145519140109,1.5985828056214526,0.05006587615283267,0.7392615180594719,1.0,2/21,1.27%,KANSL1;GLI3
prerank,GABA receptor activity (GO:0016917),-0.5221510040592442,-1.596000272729579,0.009389671361502348,0.3745379105766613,0.966,9/21,15.05%,GABRB1;GABRB3;GABRA2;GABBR1;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,protein kinase C binding (GO:0005080),0.7039376128386857,1.595866090371685,0.037800687285223365,0.725426859993061,1.0,1/43,0.01%,TOP2A
prerank,acylglycerol lipase activity (GO:0047372),-0.6414573548101983,-1.5836411998234332,0.025078369905956112,0.38629819200766,0.975,4/11,9.48%,ABHD6;ABHD12;ABHD16A;ABHD2
prerank,MHC class I protein binding (GO:0042288),-0.5946020360031748,-1.5764022579306871,0.026755852842809364,0.38394408708314215,0.982,7/13,29.47%,TAPBP;DERL1;ATP5F1A;ATP5F1B;TAP2;TUBB4B;ABCB9
prerank,four-way junction DNA binding (GO:0000400),0.7637188846257096,1.5666457085127818,0.07297297297297298,0.8728435137216042,1.0,10/17,13.94%,RAD51B;GEN1;HMGB2;XRCC2;BLM;RAD51C;HMGB3;HMGB1;MSH6;YY1
prerank,ubiquitin binding (GO:0043130),0.661278226502988,1.565158877945067,0.01702127659574468,0.8504895455023334,1.0,14/73,11.70%,TOP2A;CKS2;RNF168;NEDD4;FAF1;CXCR4;BUB3;FBXW7;UBE2N;RNF31;USP16;IKBKG;ADRM1;ILRUN
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.622296006439378,-1.563951898169304,0.04081632653061224,0.39702610605761923,0.985,6/11,24.04%,PRMT3;PRMT2;PRMT8;PRMT1;PRMT9;FBXO11
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.6968097426944787,1.5574863893435233,0.05357142857142857,0.8682801635883918,1.0,7/34,8.15%,CCNB1;INCENP;CKS2;DBF4;STK3;ETAA1;CAB39L
prerank,glutamate receptor activity (GO:0008066),-0.5207923998326907,-1.5571703697955714,0.03347280334728033,0.39529785628847247,0.988,11/19,21.39%,GRM7;GRIK1;GRM3;GRID2;GRIK4;GRIA1;GRM5;GRM1;GRIA2;GRIK2;GRID1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.4692778313522668,-1.5546305841438628,0.0374331550802139,0.3806077332507251,0.989,11/27,17.79%,APOE;HSP90B1;SYT1;LRP1;DNAJA1;RELN;AP2M1;ANKRA2;LDLRAP1;AP2A1;APBB1
prerank,RNA polymerase binding (GO:0070063),0.7457576705069833,1.550519585235067,0.07712418300653595,0.8806674025983489,1.0,4/18,4.75%,BRCA1;ANP32B;NEDD4;DHX9
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6228299421583611,-1.5479210051145107,0.057971014492753624,0.3794705299394251,0.991,6/10,13.64%,SHANK3;IGSF11;SQSTM1;SHISA6;SHANK1;DLG4
prerank,DNA polymerase binding (GO:0070182),0.7239182359455316,1.5330192006037513,0.08916323731138547,0.954291144539474,1.0,9/18,13.91%,FANCD2;RAD51;FANCI;RTEL1;SMARCA4;LONP1;HMGB1;PCNA;SMG6
prerank,5'-3' exonuclease activity (GO:0008409),0.7588583033088175,1.5302291733334028,0.08916323731138547,0.9423023413192851,1.0,2/14,5.32%,EXO1;MRE11
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5348318527962023,-1.5300441185509301,0.0502092050209205,0.3933271050695047,0.998,6/16,15.03%,ATP6V0A1;ATP6V0D1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5348318527962023,-1.5300441185509301,0.0502092050209205,0.3933271050695047,0.998,6/16,15.03%,ATP6V0A1;ATP6V0D1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,phospholipase A2 activity (GO:0004623),-0.4761842222144568,-1.5292356576231034,0.02072538860103627,0.3792395355168173,0.998,10/26,30.80%,PLA2G4A;PLAAT3;PNPLA8;PLA2G7;PLA2G12A;PLA2G15;PRDX6;PNPLA3;PLA2G4E;PLA2G4C
prerank,deoxyribonuclease activity (GO:0004536),0.745428363655924,1.528898714423484,0.09686609686609686,0.9202257674124681,1.0,4/14,10.29%,ZRANB3;ERCC4;MRE11;MBD4
prerank,protein kinase regulator activity (GO:0019887),0.6465633608659417,1.5263932671921723,0.024742268041237112,0.907069819643161,1.0,13/95,6.76%,TPX2;CCNF;CCNB1;CCNE2;CCNB2;SPDYA;PARVA;GPRC5A;CCNA2;FAF1;CCNA1;CCNE1;WNK1
prerank,WW domain binding (GO:0050699),0.7024706819843372,1.5258101087901461,0.07272727272727272,0.8847933301897497,1.0,4/26,9.25%,KIF20B;NFE2;PMEPA1;CDC25C
prerank,single-stranded telomeric DNA binding (GO:0043047),0.7730166476079676,1.5253011234863452,0.1054172767203514,0.863075771412657,1.0,9/11,18.77%,TERF1;RPA1;STN1;HNRNPA1;RPA2;TERF2;HNRNPA2B1;TERF2IP;RAD50
prerank,magnesium ion binding (GO:0000287),0.6390294597453742,1.5236683786536114,0.0060790273556231,0.8472014706030053,1.0,27/135,10.26%,TOP2A;PIF1;PLK1;FIGNL1;GEN1;MAST2;NLK;IDH3A;TDP2;DYRK3;GSS;HPRT1;NUDT5;STK3;PDXK;RAP2A;MAP3K20;HPGDS;CDC42BPA;LRRK2;PGM1;TPPP;PPA1;MARK2;TKT;EYA2;CDC42BPG
prerank,poly(U) RNA binding (GO:0008266),0.73597224175951,1.517935833186414,0.07345360824742268,0.8548719904555144,1.0,12/20,16.13%,PABPC4;PATL1;KHDRBS1;FMR1;HNRNPH1;RBMS2;ATXN1;RBMS3;DAZAP1;RBMS1;PABPC1;PNPT1
prerank,chloride channel activity (GO:0005254),-0.3788719151188932,-1.5111031723941566,0.013888888888888888,0.4095637725647019,0.999,18/59,15.73%,GABRB1;ANO3;GABRB3;GABRA2;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;CLCN7;GABRA5;GABRB2;ANO4;GABRG2;TTYH2;GABRG1;TTYH3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.49855923272577285,-1.5085129314700667,0.03759398496240601,0.3993223819746673,0.999,13/18,36.42%,PIK3R3;SOCS2;PIK3R1;SOCS5;PIK3R6;PIK3R2;WDR81;PIK3R5;SOCS6;CISH;SOCS3;CCKBR;AGAP2
prerank,nuclear export signal receptor activity (GO:0005049),0.7752109375529134,1.5036332986616043,0.10218978102189781,0.9096025912866362,1.0,5/11,6.05%,RANBP17;XPO1;XPO4;EIF4ENIF1;CSE1L
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.555023336736739,-1.4929841126126955,0.06397306397306397,0.42212355135839325,1.0,9/13,33.01%,TRMT11;THUMPD3;TRMT10B;TRMT1;METTL1;TRMT10A;WDR4;TRMT1L;TRMT10C
prerank,telomeric DNA binding (GO:0042162),0.667545175721742,1.4861017505107974,0.1162514827995255,0.9787205080843188,1.0,16/32,19.63%,PIF1;TERF1;RPA1;HNRNPD;STN1;BLM;TERF2;SMG6;HNRNPA2B1;PURA;UPF2;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.4107794584847806,-1.4843909707104348,0.04375,0.4134959471178264,1.0,18/34,25.20%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFB6;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.4107794584847806,-1.4843909707104348,0.04375,0.4134959471178264,1.0,18/34,25.20%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFB6;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,nuclease activity (GO:0004518),0.6468001856230718,1.4831969925331445,0.05417607223476298,0.9704275334772497,1.0,7/52,7.58%,EXO1;ANKLE1;REXO5;RNASE6;DNA2;MRE11;RNASEH2A
prerank,nuclear localization sequence binding (GO:0008139),0.7104999373358533,1.4806489151170417,0.12075983717774763,0.9595170782297807,1.0,7/18,15.77%,KPNA2;KPNA3;BRAP;TNPO1;NUP214;KPNA4;IPO5
prerank,transcription corepressor binding (GO:0001222),0.6865290165447867,1.4788591596817262,0.10285006195786865,0.9466587634077076,1.0,8/27,7.92%,EZH2;SUZ12;HDGF;EED;WIZ;CTBP1;LCOR;PHF1
prerank,water transmembrane transporter activity (GO:0005372),0.752569170764913,1.478057406802675,0.09235668789808917,0.9290107862678194,1.0,2/11,5.72%,AQP1;PDPN
prerank,poly-pyrimidine tract binding (GO:0008187),0.7057817802606349,1.4759899568238082,0.09367088607594937,0.9185652732541053,1.0,13/23,16.13%,PABPC4;PATL1;KHDRBS1;FMR1;HNRNPH1;RBMS2;HNRNPU;ATXN1;RBMS3;DAZAP1;RBMS1;PABPC1;PNPT1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5504677489732892,-1.4693733515715761,0.06920415224913495,0.43677846930825054,1.0,8/13,15.05%,GABRA2;GLRB;GLRA1;GABRA3;GLRA3;GABRA5;GABRG2;GABRG1
prerank,gamma-tubulin binding (GO:0043015),0.6920472226635332,1.4677105487429498,0.11838790931989925,0.9374440249982339,1.0,4/21,4.55%,RACGAP1;CDK5RAP2;BRCA2;TUBGCP5
prerank,histone deacetylase binding (GO:0042826),0.612244520538255,1.462181433717921,0.05186721991701245,0.9446774946448451,1.0,15/88,11.38%,TOP2A;KPNA2;GLI3;MIER1;SP2;BCOR;BHLHE41;LCOR;RBBP4;NIPBL;MIER3;MTA3;SFPQ;TAL1;HDAC1
prerank,DNA binding (GO:0003677),0.612122124431763,1.4618027547403425,0.0,0.9268872442758844,1.0,157/694,12.82%,TOP2A;NEIL3;BRCA1;EXO1;RAD51AP1;POLQ;NR2E3;PHF19;BRIP1;POLE;CLSPN;RAD51B;E2F2;ATAD5;RAD51;PBX4;MCM5;POLA1;GLI2;ORC1;RAD18;TCFL5;WDR76;DDX11;RAD51AP2;HMGB2;E2F1;BRCA2;TIPIN;FOXE1;MCM8;TERF1;CDC45;ILF3;DMC1;MND1;AUNIP;CCDC25;SMC1A;TIMELESS;SMC6;FAM111A;MCM10;CBFB;MCM6;SETX;MCM7;MCM2;PDS5B;TEAD1;RBBP8;HDGF;CTCF;E2F3;RPA1;NFE2;STN1;MSH3;SMARCAD1;MBD1;ERCC4;RAD1;KHDRBS1;CUX1;DNA2;TDP2;DHX9;AIFM2;PRKDC;HNRNPA1;TCF7L1;BLM;MRE11;TSHZ1;NFIB;THRAP3;MAPT;MAEL;MCM3;IKZF1;POLD1;RPA2;MCM4;GZF1;ERCC3;RFC1;YAF2;TCF7L2;PSIP1;SOX6;HP1BP3;RFC3;HOXA7;GRHL2;TCF4;DNASE2;ARID1A;RFX2;MLH1;TAF12;NUCKS1;POLR2A;POU2F1;POU3F2;SIM1;RC3H2;PHF1;LIN9;FOXO3;TRIM28;KDM2B;PLAGL2;IRF1;RAD51C;HMGB3;BCLAF1;GTF3C4;SMARCA4;MSL3;TIGD2;NFYA;CUL4B;ARID4A;PLAGL1;LONP1;HMGB1;MEOX2;NR4A2;CARF;MBD4;CXXC5;SFPQ;HNRNPU;CRLF3;XPA;GTF2A1;PCNA;CHD2;QRICH1;AHR;NKX2-1;TAF4;FANCG;APLP2;SPTY2D1;FUBP1;RBPJ;NR4A1;MSH6;ZIC4;KMT2D;SOX9;SMAD4;HDAC2;ATF5;ZNF496;ILF2
prerank,protein kinase activator activity (GO:0030295),0.6306027410294426,1.461732202313574,0.07551240560949299,0.9082560932213838,1.0,17/60,15.23%,TPX2;INCENP;DBF4;SPDYA;GPRC5A;STK3;WNK1;ETAA1;CAB39L;ABI1;MARK2;CALM2;STRADA;CAB39;STK11;RPTOR;TAOK1
prerank,exonuclease activity (GO:0004527),0.6287552970569634,1.4567348857364633,0.08415300546448087,0.9126551832178431,1.0,19/46,19.06%,EXO1;REXO5;APEX2;RAD1;MRE11;EXD1;ERI1;ENPP2;ENPP3;CNOT6;ENPP1;EXOSC7;DXO;CNOT7;EXOSC10;DCLRE1C;RAD50;XRN2;ISG20L2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.6509337230462248,1.4452906289934841,0.10885167464114832,0.9479172604768111,1.0,7/34,7.50%,EZH2;KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,phospholipase inhibitor activity (GO:0004859),0.7434524053930799,1.4420898033896334,0.12735849056603774,0.9442529999164859,1.0,4/10,11.48%,ANXA9;ANXA2;ANXA5;ANXA1
prerank,kinase activator activity (GO:0019209),0.6628455449393278,1.4397970502086028,0.11300121506682867,0.9367264416967646,1.0,9/30,14.78%,TPX2;SPDYA;GPRC5A;WNK1;MARK2;STRADA;CAB39;STK11;RPTOR
prerank,acetyltransferase activity (GO:0016407),0.6535678243895364,1.432471445431402,0.12363636363636364,0.9518256880907255,1.0,2/31,1.96%,ESCO2;NAT14
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6365805563416322,1.4307633194020846,0.11529411764705882,0.9417381566997935,1.0,4/35,2.43%,MELK;MATK;DYRK1A;STYK1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.4347357205928606,-1.4284506445475729,0.05389221556886228,0.5311175086007274,1.0,11/29,11.29%,GRIK1;GABRB1;GABRB3;GABRA2;GRID2;GRIK4;GABRA3;GLRA3;GABRA5;GABRB2;GABRG2
prerank,BMP binding (GO:0036122),-0.5687156705945146,-1.4279361378937532,0.08235294117647059,0.5160126658030358,1.0,3/11,14.92%,NBL1;BMPR2;ENG
prerank,carboxylic acid binding (GO:0031406),-0.388635292171435,-1.4271060238759001,0.05755395683453238,0.5025921725350039,1.0,9/38,7.38%,GRM7;GRIN3A;GLRB;GLRA1;GRIN2B;NOS3;SESN3;PSAP;GLRA3
prerank,lysine N-methyltransferase activity (GO:0016278),0.6742359620722701,1.425383753703915,0.14136125654450263,0.9485426509883031,1.0,6/20,7.50%,KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,voltage-gated cation channel activity (GO:0022843),-0.3331114273404199,-1.4192367741840588,0.0,0.5103304381822007,1.0,30/97,20.42%,CACNA2D1;GRIN3A;GRIN2A;KCNC2;HCN1;KCNB1;GRIN2B;KCNQ3;KCNH1;CACNG7;CACNA1B;CACNG4;KCNS3;KCNH7;OPRM1;NCS1;KCNA6;KCNA2;CACNG2;CACNB2;GRIN1;KCNC1;CACNG3;CACNG8;CACNB1;CACHD1;KCNQ1;CACNA2D2;KCNK1;LRRC38
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.48121954299288644,-1.4177636424316293,0.06343283582089553,0.49954498457131596,1.0,10/17,23.70%,GRIK1;GRIN3A;GRIN2A;GRIN2B;GRIK4;GRIA1;GRIN1;GRIA2;GRIK2;PTK2B
prerank,retinoic acid binding (GO:0001972),0.6998370150692192,1.4122457089220226,0.1635036496350365,0.9890460972930574,1.0,1/12,3.24%,CYP26B1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.49881761573699823,-1.411855022633907,0.08480565371024736,0.5012578970589616,1.0,11/15,35.26%,PIK3R3;SOCS2;PIK3R1;SOCS5;PIK3R6;PIK3R2;PIK3R5;SOCS6;CISH;SOCS3;CCKBR
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5521682637282858,-1.4105518886351334,0.11464968152866242,0.49154268464865786,1.0,7/12,14.54%,INSR;IGF1;SOCS2;PIK3R1;IGF2;IRS1;SHC1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.6454112714135649,1.4029491719269802,0.13776137761377613,1.0,1.0,6/28,11.50%,EXO1;AGO2;RNASEH2A;RPP40;RPP30;POP1
prerank,amyloid-beta binding (GO:0001540),-0.34154958595071977,-1.4028086964970266,0.029411764705882353,0.4977752119181053,1.0,29/79,18.54%,ITM2B;CST3;GRIN2A;APOE;APBA1;ITM2A;INSR;GRIN2B;TGFB2;TLR4;LRP1;EPHB2;CACNA1B;TM2D1;FZD4;CHRNA7;GRIA1;ATP1A3;CRYAB;GSAP;APBB2;PFDN5;LDLRAP1;GRIN1;GRIA2;APBB1;SORL1;NLGN1;APBA2
prerank,microtubule minus-end binding (GO:0051011),0.70332874770168,1.3976529550965748,0.14992721979621543,1.0,1.0,5/13,5.68%,HAUS4;MACF1;TUBGCP5;NUMA1;HAUS7
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.7057327587943063,1.3962607287601128,0.1652046783625731,1.0,1.0,1/12,0.46%,CDK1
prerank,ATPase binding (GO:0051117),-0.34630947912385035,-1.3953448308519147,0.02040816326530612,0.5034202235475153,1.0,31/71,24.17%,ATP6V0A1;PSEN1;ATP1B1;ATXN3;CAV1;ATP6V1E1;AR;RALB;ATP6V0A4;NCSTN;ESR1;TMEM106B;DERL1;ATP1B3;SELENOS;TRPC1;NUFIP1;NKD2;METTL21A;UBXN1;SNU13;NR1H2;SYVN1;PDE4D;SVIP;GABARAPL2;PEX26;S100A1;PIH1D1;SNX10;WFS1
prerank,nuclear import signal receptor activity (GO:0061608),0.6923155336811581,1.3936644726882208,0.15804195804195803,1.0,1.0,3/15,5.14%,KPNA2;KPNA3;TNPO1
prerank,retinoid binding (GO:0005501),0.6436571265858712,1.3870735063193635,0.15716096324461343,1.0,1.0,3/22,4.11%,CYP26B1;ABCA4;ALDH1A2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6965180978691393,1.3866655363842968,0.1613372093023256,0.9991420491562578,1.0,6/12,15.30%,PNLDC1;CNOT1;CNOT6L;CNOT6;PAN3;CNOT7
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.7084461159873118,1.3835311251334217,0.16187594553706505,0.9973958617960377,1.0,4/11,6.99%,ALDH3A1;RDH11;RDH12;RDH14
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3337855449127661,-1.3828351610024676,0.03278688524590164,0.5237460925399194,1.0,14/60,6.42%,EPHA5;ACVR1;FLT1;TEK;NTRK2;MERTK;ACVR2A;TGFBR2;INSR;ACVRL1;PDGFRB;EPHB2;NTRK3;TIE1
prerank,phospholipid transfer activity (GO:0120014),-0.4318317405427959,-1.3773955102062185,0.10849056603773585,0.5246598423347155,1.0,12/21,25.83%,CERT1;PLTP;MTTP;GLTP;TNFAIP8L3;PRELID3B;OSBPL2;PLEKHA8;PITPNC1;PRELID3A;PRELID1;ABCA3
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.6534990440388933,1.372487430350796,0.15683814303638646,1.0,1.0,3/22,9.31%,CDKN3;DUSP12;MTMR2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5451321998904576,-1.3663568014739296,0.12852664576802508,0.5422327538692403,1.0,6/11,25.07%,LEF1;ZXDC;SRRM2;GATA2;HMGA2;THAP7
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.6422367844777018,1.362270529189147,0.17684478371501272,1.0,1.0,2/21,2.68%,CDK1;CDK14
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.6422367844777018,1.362270529189147,0.17684478371501272,1.0,1.0,2/21,2.68%,CDK1;CDK14
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5250532190874682,-1.3604842473972552,0.12779552715654952,0.5442360829583328,1.0,7/12,20.57%,VEGFC;CDH5;CADM4;VEGFA;VEGFB;VEGFD;ITGB3
prerank,kinase binding (GO:0019900),0.5708954686336679,1.3529606884522103,0.002,1.0,1.0,48/434,6.99%,KIF11;PRC1;TPX2;KIF14;CCNB1;SGO1;PLK1;FAM83D;BARD1;RACGAP1;CKS2;BORA;KIF20A;AURKB;CEP192;CEP152;POLA1;CDK5RAP2;CIT;SPDYA;CNTLN;CDKN2D;FBXO5;CDKN2C;TRIML2;RB1;AURKA;TICAM1;TRIP6;TTC28;RHOA;CEP43;CDC6;GSK3B;MAPK4;CHEK2;CCNA2;ADD2;MAPT;VRK2;FAF1;EIF4ENIF1;PTPN2;MAP3K1;TCF7L2;USP37;WNK1;CDC25B
prerank,histone methyltransferase activity (GO:0042054),0.5964466237245107,1.3473108628486612,0.17639902676399027,1.0,1.0,5/32,7.50%,EZH2;KMT5A;SUZ12;EED;SETD2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.39552489537157076,-1.3454137948790268,0.06172839506172839,0.571352589228339,1.0,9/32,19.39%,KCNC2;KCNB1;KCNQ3;KCNH1;KCNS3;KCNA6;KCNA2;KCNC1;KCNQ1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.35741844810097634,-1.3442709278612168,0.058823529411764705,0.5623043923136857,1.0,8/38,6.00%,PLA2G4A;KIF16B;PLEKHA5;SNX13;WDR45B;TECPR1;SNX3;SNX21
prerank,chemorepellent activity (GO:0045499),-0.42223705966042857,-1.34356736153818,0.07272727272727272,0.551767647393741,1.0,9/25,19.19%,NRG3;SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B
prerank,lipase activity (GO:0016298),-0.3726298250021051,-1.3415417281770616,0.09243697478991597,0.5446961902975751,1.0,9/43,9.48%,LIPA;ABHD6;ABHD12;ABHD5;ABHD16A;PLA1A;LYPLA1;PNPLA8;ABHD2
prerank,methyl-CpG binding (GO:0008327),0.6221501794483816,1.3409166259545569,0.1937888198757764,1.0,1.0,4/22,11.69%,UHRF1;MBD1;CXXC5;ERH
prerank,nucleotidyltransferase activity (GO:0016779),0.652195267512467,1.3356482903202473,0.17038007863695936,1.0,1.0,9/19,16.13%,TENT2;CRPPA;NUDT5;TENT4A;PAPSS2;TUT1;TUT7;TUT4;PNPT1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.4281243686697515,-1.3351025821974034,0.1141552511415525,0.5493624855670394,1.0,9/22,17.79%,APOE;HSP90B1;SYT1;DNAJA1;AP2M1;ANKRA2;LDLRAP1;AP2A1;APBB1
prerank,MAP-kinase scaffold activity (GO:0005078),0.6960909652355247,1.333405414660313,0.17991004497751126,1.0,1.0,4/11,11.81%,KSR1;SPAG9;SH3RF1;MAPK8IP3
prerank,SH3 domain binding (GO:0017124),-0.32930288737244895,-1.3310395028274102,0.046153846153846156,0.5478680024207718,1.0,24/62,18.94%,SGIP1;ENAH;PRKN;SHANK3;RUFY2;ELMO1;WIPF1;AFAP1L1;ADAM15;PTPN22;RUFY1;ABL1;GRB2;ARHGAP27;SHANK1;SYNJ2;CASP9;CBLB;SYNJ1;CBL;GPX1;AFAP1L2;MICAL1;PTPN12
prerank,protein kinase binding (GO:0019901),0.561745912777247,1.3298019072246579,0.002,1.0,1.0,48/479,6.99%,TOP2A;KIF11;PRC1;TPX2;KIF14;CCNB1;PLK1;FAM83D;RACGAP1;CKS2;BORA;KIF20A;CEP192;CEP152;POLA1;CDK5RAP2;CIT;SPDYA;CNTLN;CDKN2D;FBXO5;PPM1D;CDKN2C;TRIML2;AURKA;TICAM1;RHOA;CEP43;MAP4K2;GSK3B;MAPK4;CHEK2;KHDRBS1;CCNA2;SPAG9;PDE3B;ADD2;MAPT;VRK2;FAF1;PTPN2;MAP3K1;TCF7L2;CAVIN3;USP37;TPR;WNK1;CDC25B
prerank,miRNA binding (GO:0035198),0.601077509872029,1.3227229549789548,0.2014388489208633,1.0,1.0,17/30,18.93%,ZC3H7A;AGO2;HNRNPA1;FMR1;MATR3;TUT7;PUM2;TUT4;RBM4;DDX21;RC3H1;HNRNPA2B1;ZC3H7B;PNPT1;RBM10;ZNF346;SPOUT1
prerank,transcription coregulator binding (GO:0001221),0.5759148515504344,1.3221738223561326,0.16871508379888267,1.0,1.0,15/50,14.81%,EZH2;CIT;SUZ12;HDGF;CTCF;EED;WIZ;CTBP1;LCOR;PHF1;AHR;SMAD4;RORA;SMAD3;PER1
prerank,double-stranded DNA binding (GO:0003690),0.5498368838041292,1.3218868861618196,0.003,1.0,1.0,77/531,10.51%,NEIL3;RAD51AP1;E2F7;E2F8;UHRF1;EN1;RAD51B;E2F2;RAD51;GLI2;TCFL5;GLI3;DDX11;RAD51AP2;HMGB2;E2F1;FOXE1;TERF1;DMC1;MND1;ZNF32;SP3;ZFP41;ELF2;TEAD1;SP2;ZSCAN29;RBBP8;HDGF;E2F3;NFE2;TFCP2L1;MSH3;MBD1;HIVEP1;CUX1;DHX9;PRKDC;BHLHE41;KLF5;SRF;TCF7L1;MRE11;ELF4;NFIB;KLF13;MAPT;SP8;HOXC4;PSIP1;ELF1;HOXA7;GMEB1;TCF4;MYBL2;RFX2;ELK1;NUCKS1;ZBTB2;POU3F2;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;ZNF23;HMGB3;CREB5;KLF11;ZIC5;ZBTB20;HMGB1;HOXB6;MEOX2;NR4A2;NR3C1;HNRNPU
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4318574306688893,-1.3195024241957702,0.10714285714285714,0.567060745163198,1.0,7/22,15.03%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.7022822109470909,1.318076075264565,0.191800878477306,1.0,1.0,3/10,7.50%,NSD2;SETD3;SETD2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.39251243703785205,-1.3148197290680648,0.09497206703910614,0.5687019971186537,1.0,9/28,15.05%,GRIK1;GABRA2;GRID2;GRIK4;GABRA3;GABRA5;CHRNA7;GABRG2;GABRG1
prerank,chloride channel regulator activity (GO:0017081),-0.4815637555473793,-1.309178430167815,0.15555555555555556,0.5735523171806931,1.0,6/14,16.13%,STX8;STX7;SGK1;WNK2;CHRNA7;VAMP8
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.4808561890078141,-1.3074865425247122,0.13432835820895522,0.5669266946407953,1.0,8/14,28.38%,SPOCK1;TIMP3;SPOCK2;SPOCK3;BST2;TIMP2;LXN;TIMP4
prerank,metalloendopeptidase activity (GO:0004222),0.5515023411483788,1.3031070638086493,0.1513903192584964,1.0,1.0,19/76,14.21%,KEL;MMP24;MMP28;MMP25;TRABD2B;MMP14;NLN;ADAMTS10;ADAMTS5;ADAMTS14;ADAMTS9;ADAMTSL2;ADAMTS2;ADAMTS16;ADAM17;ADAMTSL3;ADAM9;ADAM19;ADAMTS1
prerank,sequence-specific mRNA binding (GO:1990825),0.6846688659877412,1.301449051193845,0.18711656441717792,1.0,1.0,4/10,13.55%,TYMS;DHX9;FMR1;DHFR
prerank,mRNA methyltransferase activity (GO:0008174),-0.48699463572280255,-1.2930148201588183,0.17263843648208468,0.5941847815316513,1.0,6/12,16.24%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;CMTR1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4603197328338975,-1.2921175383514047,0.16906474820143885,0.5750428462804199,1.0,5/16,8.99%,PTPRG;PTPRB;PTPRD;PTPRZ1;PTPRO
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4603197328338975,-1.2921175383514047,0.16906474820143885,0.5750428462804199,1.0,5/16,8.99%,PTPRG;PTPRB;PTPRD;PTPRZ1;PTPRO
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.5248534069103044,-1.2915940605001257,0.17615176151761516,0.5663160266263112,1.0,3/10,13.17%,ATXN3;CYLD;YOD1
prerank,histone methyltransferase binding (GO:1990226),0.6787862103010907,1.2907161740796849,0.21013412816691504,1.0,1.0,5/11,10.14%,LCORL;WIZ;LCOR;PHF1;CBX1
prerank,ankyrin binding (GO:0030506),0.6203399917415734,1.2903942129331025,0.21997300944669365,1.0,1.0,3/19,9.41%,RHAG;SPTB;SLC8A1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.5641438087746832,1.2892009811076435,0.18454935622317598,1.0,1.0,17/60,17.68%,CDKN3;PPM1G;PPM1D;LRRC40;PHLPP2;TAB1;CTDSPL2;PPP3CA;LRRK2;LRRK1;PPP1CC;MTMR3;PTEN;CTDSPL;UBLCP1;PPP3R1;CDC14A
prerank,ion channel activity (GO:0005216),-0.30282578237456437,-1.284024426284668,0.04,0.5761613617140288,1.0,15/80,10.86%,GRIK1;GRIN3A;GABRB1;TRPM7;UNC80;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4;TMEM63B;TRPC1;CHRNA7;GRIA1;TRPM3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.6211370148461549,1.2832444006767547,0.23076923076923078,1.0,1.0,9/17,18.82%,LBR;PTGR1;DPYD;PTGR2;SRD5A3;TM7SF2;DHCR7;BLVRB;BDH2
prerank,regulatory RNA binding (GO:0061980),0.5693728474724811,1.281174616270245,0.22860492379835873,1.0,1.0,18/38,18.93%,ZC3H7A;AGO2;DHX9;HNRNPA1;FMR1;MATR3;TUT7;PUM2;TUT4;RBM4;DDX21;RC3H1;HNRNPA2B1;ZC3H7B;PNPT1;RBM10;ZNF346;SPOUT1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.45828882392598325,-1.2810322689945348,0.19377162629757785,0.5734540443554296,1.0,9/16,37.46%,CLCN7;SLC4A8;SLC1A1;SLC26A2;SLC26A6;CFTR;CLCN6;SLC26A8;SLC12A5
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.40640911393073953,-1.2756375039147023,0.13023255813953488,0.558730226503231,1.0,5/22,16.39%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.40640911393073953,-1.2756375039147023,0.13023255813953488,0.558730226503231,1.0,5/22,16.39%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,serotonin receptor activity (GO:0099589),-0.40640911393073953,-1.2756375039147023,0.13023255813953488,0.558730226503231,1.0,5/22,16.39%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5673025465057236,1.2748363873713668,0.2243958573072497,1.0,1.0,5/38,9.78%,SERPINB8;SERPINA9;ANXA2;SERPINE1;AGT
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.5303161366101101,1.2740453917712018,0.003,1.0,1.0,105/597,12.75%,BRCA1;KIF2C;E2F7;E2F8;EN1;E2F2;MCM5;POLA1;GLI2;CDK5RAP2;ORC1;TCFL5;GLI3;DDX11;HMGB2;E2F1;FOXE1;MCM8;CDC45;MCM10;ZNF32;MCM6;SP3;MCM7;MCM2;ZFP41;ELF2;TEAD1;SP2;ZSCAN29;CDC6;CTCF;E2F3;NFE2;TFCP2L1;BCOR;HIVEP1;CUX1;DHX9;BHLHE41;KLF5;SRF;TCF7L1;ELF4;NFIB;ZW10;KLF13;ZNF568;TBL1XR1;MCM3;SP8;MCM4;HOXC4;TCF7L2;SOX6;ELF1;ORC2;HOXA7;GMEB1;TCF4;PSPC1;MYBL2;RFX2;ELK1;ZBTB2;ORC3;POU3F2;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;SMAD6;ZNF23;BNC2;IRF1;CREB5;KLF11;YAP1;NONO;NFYA;ARID4A;ZIC5;ZBTB20;HMGB1;HOXB6;MEOX2;NR4A2;MBD4;NR3C1;SFPQ;HNRNPU;TAL1;HNRNPL;XPA;CPSF4;AHR;NKX2-1;TBX18;NR4A1;ZIC4;KMT2D;SOX9;SMAD4;ATF5
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.6004095433383398,1.2713622266687248,0.23657289002557544,1.0,1.0,8/20,14.74%,AK1;MAGI3;CASK;GUK1;DTYMK;TJP2;DLG1;AK7
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.4509732850619915,-1.2706716355134815,0.18315018315018314,0.5617073605752532,1.0,1/15,0.17%,PLA2G4A
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6081463018570795,1.2704063787252438,0.2242503259452412,1.0,1.0,4/18,8.48%,ALDH3A1;ALDH8A1;ALDH1A2;ALDH1A1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5568568823090339,1.269079004013286,0.21557562076749437,1.0,1.0,13/44,16.43%,EZH2;NSD2;KMT5A;EED;SETDB2;SETD3;SETD2;KMT2A;KMT2D;KMT5C;ASH1L;SETD4;SUV39H2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.5341166945355035,1.2668388970779836,0.061,1.0,1.0,36/248,12.21%,KIF18B;KIF15;KIF20B;KIF14;RAB33B;RHOA;GNG8;ABCA4;CHD1L;DNA2;DHX9;RHOT1;RAP2A;ATL2;EFL1;ATL3;GNA13;RAB22A;RAB29;AGAP3;LRRK2;MFN2;SMCHD1;GNAQ;RHOQ;DNM2;TPPP;SRPRA;ABCB10;RAB1A;ATP2B1;DRG1;RND2;RAC1;RRAS;TSR1
prerank,neuropeptide binding (GO:0042923),-0.42568663479096175,-1.2646121444427822,0.1552346570397112,0.5672034730631671,1.0,12/18,52.55%,GPR37;OPRM1;GPR149;SORL1;OPRK1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.5653518182449505,1.2645815739835926,0.23231132075471697,1.0,1.0,16/34,21.12%,PNLDC1;ERI2;CNOT1;CNOT6L;ERI1;CNOT6;PAN3;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;XRN2;PAN2;DIS3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5470815576723337,1.261378719280242,0.23255813953488372,1.0,1.0,7/48,12.53%,RHD;RHAG;AQP1;CALHM2;TRPM2;PIEZO1;TRPM4
prerank,leak channel activity (GO:0022840),0.5942165020304904,1.259184570268218,0.23482849604221637,1.0,1.0,4/18,12.54%,RHAG;KCNK2;KCNK12;KCNK6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6541320861778007,1.2587618638751248,0.24812030075187969,1.0,1.0,2/10,2.33%,CDKN2D;CDKN2C
prerank,intracellular chloride channel activity (GO:0061778),-0.4521773963779356,-1.2556217472888473,0.19081272084805653,0.5707306811674718,1.0,7/16,15.73%,ANO3;ANO6;ANO1;ANO10;ANO4;TTYH2;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4521773963779356,-1.2556217472888473,0.19081272084805653,0.5707306811674718,1.0,7/16,15.73%,ANO3;ANO6;ANO1;ANO10;ANO4;TTYH2;TTYH3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.638247394846689,1.255277963431358,0.23660714285714285,1.0,1.0,1/11,1.82%,AQP1
prerank,PDZ domain binding (GO:0030165),0.5259008528298752,1.252529870231288,0.2156448202959831,1.0,1.0,9/61,10.76%,KIF14;CIT;ATP2B4;PDZK1;TGFBR3;CRIM1;LLGL2;ERC1;ATP2B1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5699755852435466,1.2475947838768788,0.2609727164887307,1.0,1.0,3/28,2.76%,TTK;AURKB;AURKA
prerank,syntaxin binding (GO:0019905),-0.30769928680202185,-1.246627126692998,0.08823529411764706,0.5841554569095999,1.0,25/61,20.69%,UNC13B;STX8;STXBP5L;SNAP47;NAPG;SYT1;STX7;STX6;SYNPR;VPS11;SNPH;ABL1;SNAP29;SYT12;CPLX1;VAMP8;VAMP3;SNAP25;SYT10;SYPL1;RAB11A;SYT6;VPS52;SYT2;VAMP1
prerank,ATP binding (GO:0005524),0.522410635012572,1.2449656257845811,0.069,1.0,1.0,52/266,11.80%,KIF14;KIFC1;PIF1;PLK1;TRIP13;SMC4;RAD51;HASPIN;MAST2;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;RTEL1;MTHFD1L;MAP4K2;GCK;NLK;CARS2;DHX9;PMVK;DYRK3;BLM;GSS;SARS2;STK3;MYH10;PDXK;WNK1;MAP3K20;CDC42BPA;DARS2;GUK1;ABCF3;LONP1;PIM1;PPIP5K1;MARK2;PXK;P2RY1;CDC42BPG;MYO9B;TGFBR1;HNRNPU;SRPK1;PRPS1L1;PRPS1;TWF1;ABCA1;ENPP1
prerank,protein serine/threonine kinase activity (GO:0004674),0.5205286981883585,1.2424604303130253,0.05,1.0,1.0,100/334,18.84%,PBK;NEK2;MELK;CDK1;TTK;PLK1;MASTL;AURKB;NEK3;CIT;PLK4;HUNK;MAST2;MAP4K4;DYRK1A;STK17B;BMPR1A;CDK14;AURKA;MAP3K14;ROCK2;MAP4K2;GSK3B;STK10;NLK;MAPK4;CHEK2;MYLK3;CASK;PRKDC;DYRK3;VRK2;STK24;STK3;NRK;MAP3K1;WNK1;MAP3K20;CHEK1;CDC42BPA;CDK2;LRRK2;GRK5;RIOK3;MAP3K4;ROCK1;PIM1;MARK2;CSNK2A2;CDC42BPG;CAMK1D;TGFBR1;RPS6KC1;SRPK1;EIF2AK3;PRKCB;GAK;PRKCA;ULK2;PDPK1;GRK3;AAK1;CSNK1G2;SIK2;MAPKAPK3;BRD4;CDK19;PRKCE;PKMYT1;PRKD1;PRKCI;PLK2;NRBP1;VRK1;CDK8;STK11;TAOK1;PRKD2;STK39;PASK;ATP23;HIPK3;ATR;WNK3;CDKL4;CSNK1A1;MAST4;CSNK1G1;SRPK2;PIKFYVE;MAST1;PKN2;OXSR1;MAP3K8;MAPK14;LIMK2;HIPK1;RIPK1;BRAF;CAMKV
prerank,CARD domain binding (GO:0050700),-0.4540499706835792,-1.2387003573227182,0.20618556701030927,0.5949904166797813,1.0,4/14,12.06%,CARD16;CASP4;NOD1;IRGM
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5009449321078774,-1.2367681143420068,0.22123893805309736,0.5914075264037981,1.0,5/10,15.05%,GABRA2;GABRA3;GABRA5;GABRG2;GABRG1
prerank,peptidoglycan binding (GO:0042834),-0.5051629648604807,-1.2362411746237905,0.22,0.5842595237424717,1.0,3/10,15.46%,NOD1;HK1;PGLYRP1
prerank,lipase activator activity (GO:0060229),0.6388652971088922,1.2346073405891544,0.2564491654021244,1.0,1.0,4/10,15.34%,ARHGAP6;PDPK1;BTK;SRC
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5899951043067285,1.2333259605317621,0.24426450742240216,1.0,1.0,1/18,0.69%,BIRC5
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.5535234243788305,1.2292720541878357,0.26985981308411217,1.0,1.0,9/31,14.65%,UBE2T;UBE2C;UBE2S;UBE2K;UBE2N;UBE2R2;UBE2J1;UBE2QL1;BIRC6
prerank,death receptor binding (GO:0005123),0.591666534379318,1.222664578881999,0.2571041948579161,1.0,1.0,8/15,23.28%,FADD;CASP8AP2;EDA;NGF;RIPK1;FEM1B;DAB2IP;BID
prerank,amino acid:sodium symporter activity (GO:0005283),-0.49182065016278437,-1.2219175708980021,0.2356902356902357,0.6117893539388348,1.0,5/11,19.59%,SLC1A2;SLC6A1;SLC6A11;SLC1A1;SLC6A15
prerank,3'-5' exonuclease activity (GO:0008408),0.5363645053162633,1.2178624000023344,0.25788288288288286,1.0,1.0,20/45,21.23%,PNLDC1;ERI2;RAD1;CNOT6L;MRE11;POLD1;EXD1;ERI1;CNOT6;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;RAD50;XRN2;PAN2;DIS3;TRIR
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.4099155881959622,-1.21562601288874,0.19298245614035087,0.6187777902941665,1.0,10/19,21.39%,GRIK1;GABRA2;GRID2;GRIK4;GABRA3;GABRA5;GABRG2;GABRG1;GRIK2;GRID1
prerank,protein homodimerization activity (GO:0042803),0.508347542786942,1.2149223349938751,0.025,1.0,1.0,98/589,12.61%,TOP2A;CENPF;KIF20B;ECT2;CIP2A;BARD1;KNSTRN;PON1;GEN1;TERF1;CEP57;RBM44;TRIM37;TRIML2;BMPR1A;DGCR8;CEP43;UPB1;MTHFD1L;FGFR2;STK10;CRPPA;MAPK4;MSH3;CHEK2;ACTN4;KIT;WDR54;DCK;TPM4;BHLHE41;ADD2;SNX1;LHPP;SRF;BLM;GSS;DPYD;PDLIM4;NUDT5;XDH;PDXK;EXD1;SOX6;TPR;PML;FMR1;ATG7;PDGFRA;TXN;HPGDS;SPPL2B;ZBTB7B;SH3GLB1;HSPB6;FBLN5;ZHX2;DARS2;RNF40;LRRK2;GOLGA5;SMCHD1;TYR;CPQ;MTMR1;DSCAML1;CDA;TPPP;ABCB10;NPR3;AGXT;IKBKG;KMT2A;TKT;SRGAP2;MYO9B;TARS2;SFPQ;BOK;RBPMS2;XPA;PRPS1L1;PRPS1;AHR;CLCN1;TERF2;TBX18;HOGA1;ENPP1;ZHX3;APPL2;ACHE;ASMT;MSH6;GYG1;CPOX;TRIM6;SMAD4
prerank,protein phosphatase 1 binding (GO:0008157),-0.37511209838183945,-1.2134599002989692,0.17316017316017315,0.6157809885743804,1.0,7/21,22.79%,PPP1R16B;SHOC2;PPP1R3B;SH3RF2;PPP1R11;KCNQ1;PPP1R3C
prerank,protein heterodimerization activity (GO:0046982),0.505976890781656,1.2110819415246146,0.17706237424547283,1.0,1.0,35/178,16.57%,TOP2A;BARD1;SAE1;SMC1A;AURKA;SMC3;TPM4;BHLHE41;ADD2;SNX1;BMP6;TCF4;FMR1;SIM1;ZHX2;BDKRB2;IKBKG;CYBB;NR4A2;BOK;GTF2A1;AHR;ZHX3;MICU1;NR4A1;ITGB1;ARNT;VAPA;KCNB2;FXR1;ADD1;TP53;GABBR2;METTL3;ARNT2
prerank,adenyl ribonucleotide binding (GO:0032559),0.5086300933100907,1.2099843313198122,0.098,1.0,1.0,56/291,11.80%,KIF14;KIFC1;PIF1;PLK1;TRIP13;SMC4;RAD51;HASPIN;MAST2;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;RTEL1;MTHFD1L;MAP4K2;GCK;NLK;CARS2;DHX9;PMVK;DYRK3;BLM;GSS;SARS2;STK3;MYH10;PDXK;SLC19A1;WNK1;MAP3K20;CDC42BPA;DARS2;GUK1;ABCF3;LONP1;PIM1;PPIP5K1;MPPED2;MARK2;PXK;P2RY1;CDC42BPG;MYO9B;MIEF1;TGFBR1;HNRNPU;RAPGEF4;SRPK1;PRPS1L1;PRPS1;TWF1;ABCA1;ENPP1
prerank,carboxy-lyase activity (GO:0016831),0.5752914852777562,1.2077990676250976,0.28662420382165604,1.0,1.0,2/23,3.64%,ACMSD;GGCX
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.5411484785739251,1.2067873659138262,0.2765460910151692,1.0,1.0,9/34,14.65%,UBE2T;UBE2C;UBE2S;UBE2K;UBE2N;UBE2R2;UBE2J1;UBE2QL1;BIRC6
prerank,MHC protein binding (GO:0042287),-0.39841166647733695,-1.2065201829836023,0.205761316872428,0.6235149368298711,1.0,9/20,29.47%,TAPBP;DERL1;ATP5F1A;CD81;ATP5F1B;TAP2;TUBB4B;CD74;ABCB9
prerank,calcium-release channel activity (GO:0015278),0.5798490666129507,1.2055287317288839,0.2807017543859649,1.0,1.0,8/17,16.39%,ITPR1;RASA3;TRPA1;TPCN1;TRPM2;ITPR3;PKD2;TPCN2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.41861872891175117,-1.2038996999225375,0.23367697594501718,0.6219478629830936,1.0,9/16,45.73%,PIR;ETHE1;ALOX12;ADI1;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,lysophospholipase activity (GO:0004622),-0.39236366452027777,-1.2002327286376382,0.22127659574468084,0.622601979335113,1.0,7/20,14.75%,PLA2G4A;ABHD12;ABHD16A;PNPLA6;LYPLA1;GDPD3;GDPD1
prerank,endonuclease activity (GO:0004519),0.5143752714849771,1.1999850344546865,0.27973568281938327,1.0,1.0,5/49,5.32%,ANKLE1;ZRANB3;AGO2;ERCC4;MRE11
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.542761189919415,1.193780968152801,0.27261761158021713,1.0,1.0,12/28,24.20%,FADD;TRIM37;CASP8AP2;EDA;RIPK1;TRAF6;TRAF2;FEM1B;TRAF4;DAB2IP;BID;BABAM2
prerank,MAP kinase kinase activity (GO:0004708),-0.4372031589304074,-1.1936200338174365,0.23938223938223938,0.6305469292036078,1.0,4/15,3.76%,MAPK10;MAP2K6;PAK3;MAP2K5
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6001962355594154,1.191249198113839,0.28101644245142005,1.0,1.0,5/11,12.14%,ITPR1;RASA3;TRPA1;TRPM2;ITPR3
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5475734920656591,1.1892626881048571,0.2857142857142857,1.0,1.0,6/27,10.76%,AQP1;ATP2B4;ITPR1;MAGT1;CNNM4;ATP2B1
prerank,histone acetyltransferase activity (GO:0004402),0.545341706846474,1.1876836279951892,0.2974910394265233,1.0,1.0,13/30,18.39%,BRCA2;HAT1;EPC2;ARRB1;SRCAP;EPC1;MCM3AP;TADA2A;BAZ1A;KAT6A;TAF10;NAA60;NAA40
prerank,transcription cis-regulatory region binding (GO:0000976),0.49096933479361415,1.1825138691829706,0.096,1.0,1.0,85/406,16.43%,BRCA1;E2F7;E2F8;UHRF1;E2F2;CDK5RAP2;GLI3;RBL1;HMGB2;E2F1;ZBTB8A;ZFP69;RB1;SP3;SETX;ZFP41;ETV6;TWIST2;TEAD1;AGO2;CTCF;E2F3;TFDP1;NFE2;BCOR;RFXAP;ACTN4;CUX1;NFIL3;ZNF568;TBL1XR1;TCF7L2;SOX6;GRHL2;PSPC1;ELK1;SIM1;ZBTB7B;FOXO3;LMX1B;SMAD6;BNC2;IRF1;ZFP90;KLF11;YAP1;NONO;NFYA;ARID4A;PLAGL1;LONP1;ZBTB20;HMGB1;NR3C1;SFPQ;TAL1;HNRNPL;HDAC1;AHR;NKX2-1;TBX18;STOX1;TAF4;KMT2D;SOX9;SMAD4;ATF5;RORA;TWIST1;POU2F2;YY1;FOXK2;FOXM1;SMAD3;ARNT;PER1;RBAK;DR1;ATF1;NFKB1;TP53;DRAP1;PURA;ZNF25;SUV39H2
prerank,voltage-gated sodium channel activity (GO:0005248),-0.3878662714162966,-1.1811059088506073,0.2186046511627907,0.6525633443597904,1.0,6/22,14.98%,HCN1;SCN1A;SCN9A;SCN3A;SCN8A;SCN1B
prerank,U6 snRNA binding (GO:0017070),0.5923672741594017,1.1773031108623215,0.3106796116504854,1.0,1.0,8/14,18.90%,LSM3;DDX39B;TUT1;LSM2;LSM7;LSM4;PRPF4;LARP7
prerank,poly-purine tract binding (GO:0070717),0.5486792918364023,1.1758726610872428,0.3022700119474313,1.0,1.0,15/27,16.13%,PABPC4;PATL1;KHDRBS1;FMR1;RBMS2;HNRNPU;ATXN1;RBMS3;LARP4;DAZAP1;RBMS1;PABPC1;ZC3H14;DDX1;PNPT1
prerank,insulin-like growth factor binding (GO:0005520),-0.419246132464274,-1.1750198368097022,0.25177304964539005,0.6599278984718084,1.0,5/15,13.81%,ITGA6;INSR;ITGB4;IGFBP4;IGF2R
prerank,titin binding (GO:0031432),-0.4436959156353354,-1.1739403652738907,0.2762237762237762,0.6546079867075952,1.0,2/13,2.16%,CAMK2D;CALM1
prerank,sequence-specific DNA binding (GO:0043565),0.4882884510723134,1.1729601300776753,0.069,1.0,1.0,99/590,14.44%,E2F7;NR2E3;E2F8;UHRF1;EN1;PIF1;E2F2;PBX4;GLI2;TCFL5;GLI3;E2F1;FOXE1;TERF1;CBFB;ZNF32;SP3;ZFP41;ELF2;TEAD1;SP2;ZSCAN29;CTCF;E2F3;HNRNPD;NFE2;STN1;TFCP2L1;MBD1;HIVEP1;CUX1;BHLHE41;KLF5;SRF;TCF7L1;ELF4;NFIB;KLF13;MAPT;MAEL;SP8;GZF1;HOXC4;TCF7L2;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;RFX2;ELK1;POU2F1;ZBTB2;POU3F2;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;KDM2B;PLAGL2;ZNF23;CREB5;KLF11;ZIC5;LONP1;ZBTB20;KMT2A;HOXB6;MEOX2;NR4A2;NR3C1;CXXC5;HNRNPU;XPA;CPSF4;AHR;TERF2;ERH;TBX18;RBPJ;NR4A1;ZIC4;SOX9;SMAD4;HDAC2;ATF5;ELK4;RORA;HEY2;FOXL1;RARB;POU2F2;SMG6;YY1;FOXK2;SMAD3;ARNT
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5568021622765722,1.1725223063447967,0.306282722513089,1.0,1.0,6/18,13.93%,ANXA2;RAB10;ANXA1;PDLIM5;BAIAP2L1;TMOD3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.48796613534426636,1.1713534967941541,0.119,1.0,1.0,67/346,14.65%,DTL;BRCA1;NEURL1B;UHRF1;BARD1;UBE2T;UBE2C;UBE2S;RFWD3;RNF168;TRIM37;TRIML2;BRAP;PDZRN3;RNF220;UBE2K;BCOR;UHRF2;NEDD4;MYCBP2;UBR4;SIAH2;RNF43;FANCL;TRIM59;PML;UBE2N;RNFT2;PRPF19;CUL5;MEX3C;RNF31;RC3H2;UBR5;TRIM28;VPS18;RNF40;SMURF1;CUL3;UBE2R2;SH3RF1;CUL4B;OBI1;RNF145;HERC2;TRIM63;SMURF2;FBXW11;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;UBE2J1;BTRC;FBXO27;ZNRF2;FBXO25;XIAP;RC3H1;HLTF;TRIM5;RNF114;UBE2QL1;ZNRF1;ZFP91;BIRC6
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3608130903295052,-1.1663586772668837,0.27040816326530615,0.6641978090061674,1.0,6/23,4.87%,KIF16B;PLEKHA5;WDR45B;CLVS1;SNX14;SNX3
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.4230314274017855,-1.1661229308356498,0.2852112676056338,0.6566985079014664,1.0,7/13,20.96%,PIP4K2A;PIP4K2B;PIK3C2B;PIP5K1A;PIK3CD;PIK3CA;PIP4K2C
prerank,vitamin D receptor binding (GO:0042809),0.5663598193825,1.165347352981123,0.3024251069900143,1.0,1.0,5/14,13.65%,MED14;THRAP3;MED30;MED24;MED1
prerank,voltage-gated ion channel activity (GO:0005244),-0.4302410228384493,-1.165138982788427,0.2837370242214533,0.6513220642857555,1.0,4/14,9.49%,HCN1;ANO6;GPR89B;GPR89A
prerank,metallopeptidase activity (GO:0008237),0.4884345859804815,1.1638110273098914,0.2578680203045685,1.0,1.0,23/113,14.21%,KEL;BMP1;MMP24;MMP28;MMP25;TRABD2B;MMP14;ADAM12;NLN;ADAMTS10;ADAMTS5;ADAMTS14;ADAMTS9;ADAMTSL2;PSMD14;ADAMTS2;ADAMTS16;ADAM17;ADAMTSL3;ADAM9;ADAM19;BRCC3;ADAMTS1
prerank,metal ion binding (GO:0046872),0.4857392140047465,1.162874722629197,0.096,1.0,1.0,70/477,12.92%,TOP2A;EFCAB11;MELK;PIF1;PLK1;PON1;FIGNL1;GEN1;CDH15;MAST2;LOXL2;ADGRV1;PLSCR2;SCUBE1;CDH18;CDH24;ANXA9;ANXA2;FBN1;NLK;ITPR1;PAM;IDH3A;TDP2;TPM4;DYRK3;PRNP;GSS;HPRT1;CDH4;NUDT5;STK3;ANXA3;PDXK;RAP2A;ANXA5;NDUFAB1;CABCOCO1;MAP3K20;ENPP2;HPGDS;PPP3CA;CDC42BPA;ENPP3;LRRK2;FKBP9;PGM1;ATP2A2;TPPP;SLC8A1;PPA1;MARK2;TKT;EYA2;CDC42BPG;TRPM2;CALM2;SRPK1;ANXA1;ENPP1;CALB1;MICU1;ITPR3;MSH6;TRPM4;POSTN;SIK2;MEX3B;DUT;MAN1C1
prerank,pseudouridine synthase activity (GO:0009982),-0.4345405074571303,-1.1627619473061546,0.2902097902097902,0.6494497035627453,1.0,11/13,43.84%,PUS10;TRUB1;DKC1;PUS3;RPUSD4;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.45042701244177547,-1.1592360673181918,0.3023255813953488,0.6500095253398889,1.0,5/10,18.25%,PIK3R3;PIK3C2B;ATM;PIK3CD;PIK3CA
prerank,E-box binding (GO:0070888),0.5159019775606838,1.155498967573833,0.31652989449003516,1.0,1.0,9/34,17.40%,ATOH8;ZEB1;BHLHE41;TCF4;TAL1;AHR;TWIST1;PER1;TFAP4
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.515700200595568,1.1550283146020577,0.31585081585081587,1.0,1.0,14/33,21.12%,PNLDC1;ERI2;CNOT6L;ERI1;CNOT6;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;XRN2;PAN2;DIS3
prerank,SUMO binding (GO:0032183),0.5845006919123049,1.1543647333463907,0.3154269972451791,1.0,1.0,8/13,23.72%,CASP8AP2;SERBP1;PML;HERC2;SIMC1;RNF111;UBA2;USP25
prerank,acetylation-dependent protein binding (GO:0140033),0.5461818299794456,1.1534002167245827,0.3105263157894737,1.0,1.0,9/20,20.71%,BRD9;PHIP;SMARCA4;KMT2A;BRD4;MLLT3;PSME4;ATAD2B;TRIM24
prerank,lysine-acetylated histone binding (GO:0070577),0.5461818299794456,1.1534002167245827,0.3105263157894737,1.0,1.0,9/20,20.71%,BRD9;PHIP;SMARCA4;KMT2A;BRD4;MLLT3;PSME4;ATAD2B;TRIM24
prerank,GTPase regulator activity (GO:0030695),0.48193643892196436,1.1526244455642645,0.22645290581162325,1.0,1.0,41/212,10.56%,IQGAP3;ECT2;RACGAP1;ARHGAP22;ARHGAP11A;USP6NL;IQGAP2;RGS12;GPSM2;ARHGAP10;ARHGAP28;ASAP1;DEPDC5;EVI5L;ACAP2;TBC1D25;ARHGAP18;OCRL;STXBP5;TBC1D13;ARRB1;CDC42EP2;TBC1D2B;ASAP2;ARHGAP24;LRRK2;ALDH1A1;SYDE2;GNAQ;ARHGAP19;RGS3;CPEB2;TBC1D7;LLGL2;RIC8B;NPRL3;RANGAP1;SRGAP2;MYO9B;ARHGAP35;ERRFI1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5694293396382748,1.152536207462618,0.31824611032531824,1.0,1.0,7/14,19.62%,RPP40;TSEN34;RPP30;POP1;TSEN2;PRORP;RPP21
prerank,signal sequence binding (GO:0005048),0.5141871823120645,1.152198132640496,0.31535756154747946,1.0,1.0,4/35,5.14%,KPNA2;KPNA3;BRAP;TNPO1
prerank,lipid phosphatase activity (GO:0042577),-0.42790968057392764,-1.15197864355195,0.26996197718631176,0.6601018935913398,1.0,5/14,21.13%,PLPPR1;PLPP3;INPP5K;EPHX2;PLPPR4
prerank,5'-nucleotidase activity (GO:0008253),-0.43521730671334974,-1.1513985063080667,0.28619528619528617,0.6539041583435379,1.0,6/13,30.03%,NT5M;NT5C3B;NT5DC1;NT5DC3;NT5C3A;NT5C1A
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.2865235511661299,-1.1492967971878327,0.17708333333333334,0.6515787290802075,1.0,25/57,25.20%,COX4I1;COX5A;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;NDUFB6;COX8A;NDUFB10;NDUFA10;UQCRC1;COX5B;NDUFS6;NDUFA1
prerank,protein tyrosine kinase activity (GO:0004713),0.4901943589272145,1.1482542710163857,0.2893401015228426,1.0,1.0,13/108,7.61%,MELK;TTK;WEE1;MATK;DYRK1A;STYK1;BAZ1B;FGFR4;FGFR2;KIT;MUSK;PDGFRA;EPHA4
prerank,ion gated channel activity (GO:0022839),-0.3622686222980007,-1.13949832474174,0.27751196172248804,0.6679879543119468,1.0,9/24,15.73%,ANO3;ANO6;ANO1;ANO10;TMEM63B;ANO4;KCNT1;TTYH2;TTYH3
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5581704996988911,1.136132785348707,0.3151432469304229,1.0,1.0,2/15,10.21%,GPR171;P2RY1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5131278032240465,1.1339949924511523,0.33690476190476193,1.0,1.0,8/34,13.10%,RACGAP1;IQGAP2;GBF1;ZFYVE16;ZFYVE1;MAPKAP1;CYTH3;BTK
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3893249607535322,-1.1337786516188748,0.26666666666666666,0.6753092330269946,1.0,17/18,61.11%,DHRS11;HSD17B7;HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,single-stranded RNA binding (GO:0003727),0.49659802203064307,1.132328098513169,0.33760186263096625,1.0,1.0,12/43,15.54%,DDX11;ILF3;AGO2;DHX9;HNRNPA1;EIF4H;FMR1;LONP1;HNRNPU;STRBP;AQR;FXR1
prerank,dynactin binding (GO:0034452),0.571414363875278,1.131516347103193,0.3352192362093352,1.0,1.0,3/12,6.64%,GSK3B;MAPT;BICD2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.48228939382167213,1.1300268546788075,0.32426778242677823,1.0,1.0,12/69,16.80%,ESCO2;CERS6;CERS5;SOAT1;PORCN;ZDHHC18;SOAT2;ZDHHC15;HHAT;KAT6A;ZDHHC3;ZDHHC21
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.4451014191068482,-1.1297884463189738,0.3323170731707317,0.6773685915875219,1.0,5/11,37.85%,KCNJ3;KCNQ1;KCNJ8;KCNE4;KCNH2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.5166051345040334,1.1288211727036053,0.35315101070154575,1.0,1.0,10/29,17.33%,CIT;CDKN2D;CDKN2C;PKIG;SPRED1;CDKN1B;RPTOR;SPRED2;PRKAR2B;PRKAR2A
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.40362348561942185,-1.1234822656573011,0.2974910394265233,0.6850939198513053,1.0,10/15,55.23%,CCR9;CMKLR1;CX3CR1;CCR5;CCR2;GPR17;CCRL2;CCR1;ACKR4;CCR6
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5489828203050366,1.1227983033857303,0.3342541436464088,1.0,1.0,3/15,8.48%,ALDH3A1;ALDH1A2;ALDH1A1
prerank,leucine zipper domain binding (GO:0043522),0.5810629586388343,1.1197679984603548,0.36321483771251933,1.0,1.0,3/10,11.77%,PMF1;ERC1;MRTFA
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5425256103041819,1.1186482746052522,0.348993288590604,1.0,1.0,6/16,16.15%,MTMR14;MTMR1;MTMR2;MTMR9;MTMR3;PTEN
prerank,cation:chloride symporter activity (GO:0015377),-0.4705484624441887,-1.1165850468570568,0.34534534534534533,0.6946111193376084,1.0,3/10,16.25%,SLC6A1;SLC12A9;SLC12A2
prerank,actinin binding (GO:0042805),0.52046849536462,1.1161953768792654,0.35316946959896506,1.0,1.0,8/21,15.76%,CSRP2;PDLIM4;CACNA1C;PDLIM5;SYNPO2;PKD2;CSRP3;NFKB1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5549989011691219,1.1152502487205325,0.35244755244755244,1.0,1.0,6/14,16.15%,MTMR14;MTMR1;MTMR2;MTMR9;MTMR3;PTEN
prerank,insulin-like growth factor I binding (GO:0031994),-0.41176033550234964,-1.114510127926513,0.32601880877742945,0.6918899194270796,1.0,4/13,12.36%,ITGA6;INSR;ITGB4;IGFBP4
prerank,tau protein binding (GO:0048156),-0.30656533932415664,-1.1144084074646337,0.26277372262773724,0.6847011358128628,1.0,12/40,7.83%,EP300;MARK3;HSP90AB1;ACTB;APOE;BIN1;TAOK2;BRSK1;PRKAA1;PPP2CB;LGMN;MAP1A
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.341152947794198,-1.113307859135668,0.31,0.680538443305453,1.0,8/27,19.27%,SLC22A8;ANO1;SLC22A6;SLC5A5;SLC26A11;SLC25A11;LRRC8A;SLC26A2
prerank,neuropeptide receptor activity (GO:0008188),-0.3305740304047562,-1.1107191175702185,0.2781065088757396,0.6794313507857598,1.0,5/29,10.55%,SORCS3;SORCS1;GPR37;OPRM1;HCRTR2
prerank,nucleotidase activity (GO:0008252),-0.4014587580320629,-1.1085929506421464,0.33941605839416056,0.6772807238866145,1.0,7/15,30.03%,BPNT2;NT5M;NT5C3B;NT5DC1;NT5DC3;NT5C3A;NT5C1A
prerank,calcium-activated potassium channel activity (GO:0015269),0.5745019302406204,1.1039696033358188,0.3710144927536232,1.0,1.0,4/11,14.80%,KCNN4;KCNMB2;KCNMB3;KCNMB4
prerank,platelet-derived growth factor binding (GO:0048407),-0.44622159327692545,-1.10045848076754,0.33774834437086093,0.6900390312201402,1.0,4/11,9.22%,COL6A1;PDGFRB;COL5A1;COL1A2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4020756530558145,-1.0996871415177478,0.3333333333333333,0.6851088456447662,1.0,6/14,37.85%,KCNJ3;KCNQ1;KCNJ8;KCNIP2;KCNE4;KCNH2
prerank,protein tyrosine kinase binding (GO:1990782),-0.25180273244794327,-1.0978221156856782,0.1509433962264151,0.6827146597055719,1.0,24/71,18.99%,NRG3;ACVR1;GRB14;BMPR2;NEDD9;GAS6;SQSTM1;CDH5;DUSP3;DUSP22;SOCS5;TOB1;FLT3LG;ANGPT2;GRM5;PTPN14;PTPN11;SHC1;ELMO2;CBLB;FIZ1;CBL;SHC4;SHC3
prerank,sodium channel activity (GO:0005272),-0.31115926343307476,-1.0975497492050397,0.3356164383561644,0.6765481714384478,1.0,10/37,21.29%,GRIK1;HCN1;SCN1A;GRIK4;SCN9A;SCN3A;SCN8A;SCN1B;KCNK1;GRIK2
prerank,thyroid hormone receptor binding (GO:0046966),0.5092416011128411,1.0963253454167523,0.3743961352657005,1.0,1.0,12/28,20.08%,TRIP6;THRAP3;MED30;MED24;ZNHIT3;TRIP12;MED1;JMJD1C;BRD8;ARID5A;MED16;GTF2B
prerank,copper ion binding (GO:0005507),0.4860464344159933,1.0962569266840776,0.36610169491525424,1.0,1.0,10/42,17.81%,LOXL3;LOXL2;PAM;PRNP;SOD3;TYR;COA6;TP53;CCS;LACC1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.4617823890944392,1.0953184564309741,0.255,1.0,1.0,83/431,13.74%,KIF14;KIFC1;PIF1;PLK1;TRIP13;SMC4;RAD51;RANBP17;TUBB6;HASPIN;MAST2;TUBA1C;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;TUBE1;RTEL1;RHOA;MTHFD1L;MAP4K2;GCK;NLK;RAB10;CARS2;RRAD;DHX9;PMVK;DYRK3;BLM;GSS;SARS2;RHOT1;STK3;MYH10;PDXK;RAP2A;ATL2;WNK1;MAP3K20;ATL3;RAB22A;CDC42BPA;RAB29;RASEF;TUBD1;DARS2;LRRK2;GUK1;ABCF3;RHOQ;DNM2;LONP1;PIM1;PPIP5K1;MARK2;PXK;P2RY1;CDC42BPG;MYO9B;TGFBR1;HNRNPU;DRG1;SRPK1;PRPS1L1;PRPS1;TWF1;RND2;RAC1;ABCA1;ENPP1;RRAS;SEPHS1;TSR1;MSH6;SIK2;BTK;PRKCI;DRG2;ARF4;MVK
prerank,chloride channel inhibitor activity (GO:0019869),-0.45152930239581984,-1.0952978620718126,0.3508771929824561,0.6751240694619469,1.0,3/10,5.02%,STX8;STX7;WNK2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5658259529268344,1.0949038833375662,0.37765205091937765,1.0,1.0,4/12,18.82%,AIFM2;NQO1;CRYZL1;DHRS4
prerank,actin binding (GO:0003779),0.45903283508553994,1.0933683019745004,0.33634538152610444,1.0,1.0,47/170,17.61%,KIF18A;GAS2L3;ANLN;VASH2;IQGAP2;SYNE2;MACF1;SPTB;PARVA;ACTN4;SPEF1;ADD2;SLC6A2;MAPT;PDLIM4;SSH2;MYH10;MICAL3;MLPH;CXCR4;PHACTR1;LRRK2;EPS8L1;EMD;MYO9B;HNRNPU;SMTN;TWF1;CAPZA1;EZR;PHACTR2;MRTFA;PDLIM5;DMTN;SYNPO2;PRKCE;TLN2;ITGB1;ADD1;LCP1;DBN1;PLEKHH2;TNNT3;VPS16;COBL;SHROOM2;TRPV4
prerank,semaphorin receptor binding (GO:0030215),-0.3514501826788736,-1.0924575102038157,0.2897727272727273,0.6752629885814431,1.0,17/23,38.73%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B;RIT2;SEMA6C;SEMA3G;SEMA4C;SEMA4A;SEMA3E;SEMA4G;SEMA3F;SH3BP1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5556005883163139,1.0921595304300706,0.37976539589442815,1.0,1.0,5/12,10.92%,TENT2;TENT4A;TUT1;PAPOLB;TENT5D
prerank,ATPase activator activity (GO:0001671),-0.35940505469539674,-1.0918000734854334,0.328125,0.6703244918457963,1.0,5/20,9.08%,ATP1B1;DNAJC24;DNAJC19;DNAJA1;ATP1B3
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5776291107631705,1.091726444257382,0.37367624810892586,1.0,1.0,3/10,8.81%,BRCA2;HAT1;MSL3
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2725163203361922,-1.0897805612251836,0.23595505617977527,0.6687600326677744,1.0,19/56,18.99%,NRG3;GRB14;GAS6;SQSTM1;PIK3R1;DUSP3;SOCS5;TOB1;IRS1;FLT3LG;ANGPT2;PTPN14;SHC1;ELMO2;CBLB;FIZ1;CBL;SHC4;SHC3
prerank,symporter activity (GO:0015293),-0.45056908121044825,-1.0884660923476466,0.3741721854304636,0.6654950975966866,1.0,3/10,23.34%,SLC5A6;SLC5A5;MFSD2A
prerank,adenylate cyclase binding (GO:0008179),-0.4424156208814556,-1.0841653192751373,0.34818941504178275,0.6694218367174519,1.0,3/10,6.65%,CALM1;AKAP6;CAP1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5408086499044175,1.0830412609083968,0.371994342291372,1.0,1.0,3/13,8.48%,ALDH3A1;ALDH1A2;ALDH1A1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3869144819655993,-1.0821063631943042,0.36330935251798563,0.6682373586125341,1.0,3/15,4.87%,PLA2G4A;PLEKHA5;SNX3
prerank,fibroblast growth factor binding (GO:0017134),0.5221157790713746,1.0806800072395844,0.37763157894736843,1.0,1.0,4/21,9.45%,CEP57;FGFR4;FGFR2;FGFRL1
prerank,calcium channel regulator activity (GO:0005246),-0.3020605141415046,-1.0800546948265837,0.3380281690140845,0.6665180914441666,1.0,13/37,21.15%,PRKG1;CALM1;FKBP1A;SGK1;CACNG7;NRXN1;CACNG4;SLC30A1;SRI;CACNG8;INAFM1;REM1;PACSIN3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.529268196988336,1.0753480260434312,0.38461538461538464,1.0,1.0,2/14,5.89%,RDH11;RDH12
prerank,pre-mRNA binding (GO:0036002),0.4965421038889121,1.0750567774363762,0.38636363636363635,1.0,1.0,8/28,13.48%,TRA2B;HNRNPA1;SLBP;ERI1;CELF2;HNRNPU;HNRNPL;RBM4
prerank,GTPase activator activity (GO:0005096),0.4508496223102168,1.073581616963671,0.336,1.0,1.0,61/313,11.27%,IQGAP3;ECT2;RACGAP1;PCP2;ARHGAP22;ARHGAP11A;USP6NL;IQGAP2;RANGRF;DENND2C;ARHGAP10;FNIP1;ARHGAP28;ASAP1;RCBTB2;DEPDC5;EVI5L;MYCBP2;ACAP2;TBC1D25;ARHGAP18;OCRL;DENND4C;STXBP5;TBC1D13;DNMBP;FGD4;EIF2B1;DENND2A;ARRB1;CDC42EP2;VAV2;TBC1D2B;FGD1;ASAP2;ARHGAP24;ANKRD27;LRRK2;RAB3IL1;ALDH1A1;SYDE2;GNAQ;ARHGAP19;RGS3;TBC1D7;FARP1;LLGL2;EPS8L1;RIC8B;NPRL3;RANGAP1;DENND5A;SRGAP2;MYO9B;HERC2;ARHGAP35;ERRFI1;CYTH3;FGD6;RAPGEF4;ARHGEF18
prerank,vinculin binding (GO:0017166),0.5559312091670998,1.0726200941269313,0.3941176470588235,1.0,1.0,4/11,11.43%,CTNNA1;SORBS3;TLN1;SYNM
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4968094913688607,1.0715297528424579,0.40294840294840295,1.0,1.0,5/27,7.48%,PRIM1;POLR1A;PRIMPOL;POLR1B;POLR2A
prerank,phosphatase binding (GO:0019902),0.4482280979975525,1.0640234976638119,0.4004085801838611,1.0,1.0,30/105,18.69%,NEK2;CEP192;MAST2;ANAPC7;KCNN4;CDC27;PDLIM4;RPA2;ANK1;WNK1;MTMR9;EIF2AK3;AP3B1;CHCHD3;DLG1;SPRED1;CDKN1B;SMAD3;MTMR3;TP53;ANAPC5;PPP3R1;SIRPA;PPME1;MVP;SMAD2;TERF2IP;BAD;MAPK14;KIFAP3
prerank,channel activity (GO:0015267),0.4653448796895667,1.0639788053410926,0.4070695553021665,1.0,1.0,6/41,12.04%,AQP1;TRPA1;PDPN;MCUB;SLC14A1;CHRNB1
prerank,Notch binding (GO:0005112),-0.33163931202913655,-1.0602720499966203,0.3700440528634361,0.7076977566149324,1.0,9/22,20.56%,DNER;SNED1;JAG1;KCTD10;DTX1;JAG2;NOTCH4;SNW1;HIF1AN
prerank,ribonuclease P activity (GO:0004526),0.5347480628687908,1.0547761678007028,0.39821693907875183,1.0,1.0,5/11,19.62%,RPP40;RPP30;POP1;PRORP;RPP21
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5340173077443888,1.0544453278738677,0.41459627329192544,1.0,1.0,3/12,8.18%,AGO2;EIF4E;LARP1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.43924671385539504,1.0541641045243944,0.306,1.0,1.0,130/732,15.88%,E2F7;NR2E3;E2F8;UHRF1;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;TCFL5;GLI3;HMGB2;E2F1;FOXE1;ATOH8;ZNF32;PBX3;SP3;HOXC5;TEAD1;SP2;ZSCAN29;CTCF;E2F3;ZEB1;NFE2;TFCP2L1;ZNF260;NFIA;HIVEP1;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;ELF4;NFIB;THRAP3;KLF13;ZNF568;ZNF697;CCAR1;SP8;IKZF1;GZF1;HOXC4;TCF7L2;SOX6;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;GLIS3;RFX2;ELK1;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;ZBTB7B;PRRX2;OLIG2;FOXO3;ZNF23;IRF1;CREB5;KLF11;ZBTB25;HOXB3;NFYA;PLAGL1;ZIC5;ZBTB20;HOXB6;MEOX2;NR4A2;CARF;MYPOP;NR3C1;HNRNPU;TAL1;TEAD3;ZBTB24;KCNIP3;ZNF585B;ZNF585A;CHD2;HDAC1;AHR;NKX2-1;KLF9;TBX18;RBPJ;NR4A1;ZIC4;SOX9;SMAD4;ZNF394;ZNF496;ELK4;RORA;HEY2;FOXL1;RARB;POU2F2;YY1;FOXK2;DNMT3A;RUVBL2;SMAD3;ARNT;FOXP4;SOX1;E2F4;PER1;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,mRNA 3'-UTR binding (GO:0003730),0.450290436410164,1.0522049235479267,0.4228751311647429,1.0,1.0,26/79,15.84%,ILF3;PABPC4;LARP4B;SERBP1;FMR1;YBX3;RBMS2;CELF2;LARP1;TUT1;RNF40;CPEB2;PUM2;HNRNPU;RBMS3;MEX3D;RBM4;LARP4;DAZAP1;RC3H1;RBMS1;PABPC1;SECISBP2;HNRNPA2B1;FXR1;TP53
prerank,LRR domain binding (GO:0030275),0.5265940776196343,1.0489760063464726,0.43446244477172313,1.0,1.0,4/14,11.77%,PMF1;ROBO1;ERC1;MRTFA
prerank,voltage-gated calcium channel activity (GO:0005245),-0.29115554348811706,-1.04861670991469,0.3333333333333333,0.7281788218680978,1.0,13/37,19.61%,CACNA2D1;CACNG7;CACNA1B;CACNG4;OPRM1;NCS1;CACNG2;CACNB2;CACNG3;CACNG8;CACNB1;CACHD1;CACNA2D2
prerank,phosphatase activator activity (GO:0019211),0.5116729305364153,1.046352967249037,0.41597796143250687,1.0,1.0,6/14,20.14%,FRS2;PPP2R5C;CALM2;BMP2;PPP2R5B;PHACTR4
prerank,hexosaminidase activity (GO:0015929),0.5212304109143353,1.044636669173949,0.41317365269461076,1.0,1.0,2/12,3.29%,SPAM1;HYAL1
prerank,ubiquitin protein ligase activity (GO:0061630),0.4333810470729957,1.0442211277207991,0.4314314314314314,1.0,1.0,47/228,15.66%,NEURL1B;UHRF1;RFWD3;TRIM37;TRIML2;BRAP;PDZRN3;RNF220;UBE2K;UHRF2;NEDD4;MYCBP2;UBR4;SIAH2;RNF43;FANCL;TRIM59;RNFT2;PRPF19;MEX3C;RC3H2;UBR5;VPS18;SMURF1;CUL3;SH3RF1;RNF145;HERC2;UBOX5;TRIM63;SMURF2;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;FBXO27;ZNRF2;XIAP;RC3H1;HLTF;TRIM5;RNF114;ZNRF1;FBXO17;NSMCE1;ASB2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4300849157033421,1.0413794134383485,0.44544544544544545,1.0,1.0,40/188,15.84%,BRCA1;CDK5RAP2;HMGB2;CTCF;LIN54;BCOR;DHX9;ZNF568;TBL1XR1;TCF7L2;SOX6;PSPC1;ELK1;FOXO3;SMAD6;BNC2;IRF1;KLF11;YAP1;NONO;NFYA;ARID4A;ZBTB20;HMGB1;SFPQ;TAL1;HNRNPL;AHR;NKX2-1;TBX18;KMT2D;SMAD4;ATF5;POU2F2;YY1;FOXK2;SMAD3;PER1;NFKB1;TP53
prerank,fatty acid synthase activity (GO:0004312),-0.42165152275028606,-1.0391422319706332,0.3805309734513274,0.7444800856918486,1.0,6/10,34.54%,ELOVL7;ELOVL6;CBR4;ELOVL1;OXSM;MCAT
prerank,phospholipase activity (GO:0004620),-0.25204126788336345,-1.0369088346095205,0.359375,0.7432128647395051,1.0,11/67,9.38%,PLA2G4A;PLAAT3;ABHD6;ABHD12;ABHD16A;PNPLA6;LYPLA1;PLCB3;PNPLA8;GPLD1;PLD3
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.39861700061099586,-1.0326339491480736,0.4006849315068493,0.746964578484083,1.0,6/13,20.57%,IL1R1;PDGFRB;PDGFD;VEGFA;VEGFD;ITGB3
prerank,hormone receptor binding (GO:0051427),-0.38732429356785647,-1.0304369984001396,0.40794223826714804,0.7462510718506528,1.0,5/14,27.51%,SOCS2;JAK2;PTHLH;ADCYAP1;JAK1
prerank,CoA hydrolase activity (GO:0016289),-0.35539567310284326,-1.0265244991660085,0.4392857142857143,0.7493896455286524,1.0,6/16,25.11%,ACOT11;NUDT7;ACOT7;ACOT13;HIBCH;ACOT6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5409844526092438,1.025505953934689,0.4583333333333333,1.0,1.0,3/10,17.81%,ADA;CDA;LACC1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.4287323847482347,1.0238253149440544,0.453,1.0,1.0,42/269,11.41%,BRCA1;CCNB1;UBE2T;UBE2C;RAD18;SMC6;TRIM37;RB1;TRIOBP;GSK3B;UBE2K;GPI;NLK;DDRGK1;CHEK2;FAF1;RPA2;SLF1;CXCR4;FANCL;ARRB1;PML;FBXW7;UBE2N;CUL5;POLR2A;RNF31;STAM;TRIM28;RNF40;MFN2;SMAD6;CUL3;AXIN2;CUL4B;PSMD1;IKBKG;PARP9;HERC2;UBOX5;ARRDC1;BAG5
prerank,aspartic-type endopeptidase activity (GO:0004190),0.517807739536233,1.0232088684086225,0.45255474452554745,1.0,1.0,2/12,7.73%,CTSE;SPPL2B
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4185326258017591,-1.0231962857101617,0.43010752688172044,0.7508939008539731,1.0,6/10,26.07%,DPP9;DPP8;PRCP;DPP10;FAP;DPP3
prerank,myosin binding (GO:0017022),0.44583353149386495,1.0226243166375237,0.45792349726775955,1.0,1.0,10/55,9.30%,TRIOBP;TRAK1;RHOA;KIRREL1;RAB10;STXBP5;MLPH;CXCR4;SPATA6;LLGL2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.50638298854488,1.0213489737038826,0.4264705882352941,1.0,1.0,7/12,24.72%,POU2F1;GTF2A1;HDAC1;RUVBL2;GTF2B;H3-3A;RELA
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.4247748234786705,1.019605880598093,0.431,1.0,1.0,147/831,15.88%,E2F7;NR2E3;E2F8;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;TCFL5;GLI3;RBL1;E2F1;FOXE1;ATOH8;ZBTB8A;ZFP69;ZNF32;RB1;PBX3;SP3;HOXC5;ZFP41;ETV6;TWIST2;TEAD1;SP2;ZSCAN29;CTCF;E2F3;ZEB1;TFDP1;NFE2;TFCP2L1;RFXAP;ACTN4;ZNF260;NFIA;HIVEP1;CUX1;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;ELF4;NFIB;THRAP3;KLF13;ZNF568;ZNF697;CCAR1;SP8;IKZF1;GZF1;HOXC4;TCF7L2;SOX6;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;GLIS3;RFX2;ELK1;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;SIM1;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;ZNF23;IRF1;CREB5;ZFP90;KLF11;ZBTB25;HOXB3;NFYA;PLAGL1;ZIC5;ZBTB20;HOXB6;MEOX2;NR4A2;CARF;MYPOP;NR3C1;HNRNPU;TAL1;TEAD3;ZBTB24;KCNIP3;GTF2A1;ZNF585B;ZNF585A;CHD2;HDAC1;NKX2-1;KLF9;TBX18;STOX1;RBPJ;NR4A1;ZIC4;SOX9;SMAD4;ZNF394;ATF5;ZNF496;ELK4;RORA;TWIST1;HEY2;FOXL1;RARB;POU2F2;YY1;FOXK2;DNMT3A;RUVBL2;FOXM1;SMAD3;ARNT;FOXP4;SOX1;E2F4;PER1;RBAK;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,histone deacetylase activity (GO:0004407),0.49174985346870903,1.0194316635979872,0.4468629961587708,1.0,1.0,9/19,22.44%,MIER1;MIER3;HDAC8;HDAC1;HDAC2;HDAC4;SIRT2;SIRT3;MIER2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.42133041963893836,1.0147864349050686,0.4939879759519038,1.0,1.0,46/232,15.66%,NEURL1B;UHRF1;RFWD3;TRIM37;TRIML2;BRAP;PDZRN3;RNF220;UHRF2;NEDD4;MYCBP2;UBR4;SIAH2;RNF43;FANCL;TRIM59;RNFT2;PRPF19;MEX3C;RC3H2;UBR5;VPS18;SMURF1;CUL3;SH3RF1;RNF145;HERC2;TRIM63;SMURF2;NSMCE2;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;FBXO27;ZNRF2;XIAP;RC3H1;HLTF;TRIM5;RNF114;ZNRF1;FBXO17;NSMCE1;ASB2
prerank,bHLH transcription factor binding (GO:0043425),0.4840325792161677,1.0145153878173203,0.4375821287779238,1.0,1.0,4/19,14.35%,FHL2;BHLHE41;TWIST1;SMAD3
prerank,phospholipase activator activity (GO:0016004),0.522481198482142,1.0126884922585104,0.46142208774583965,1.0,1.0,4/10,15.34%,ARHGAP6;PDPK1;BTK;SRC
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4218867642754015,1.0118090394860897,0.469,1.0,1.0,129/731,15.88%,E2F7;NR2E3;E2F8;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;TCFL5;GLI3;E2F1;FOXE1;ATOH8;ZNF32;PBX3;SP3;HOXC5;TEAD1;SP2;ZSCAN29;CTCF;E2F3;ZEB1;NFE2;TFCP2L1;ZNF260;NFIA;HIVEP1;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;ELF4;NFIB;THRAP3;KLF13;ZNF568;ZNF697;CCAR1;SP8;IKZF1;GZF1;HOXC4;TCF7L2;SOX6;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;GLIS3;RFX2;ELK1;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;ZBTB7B;PRRX2;OLIG2;FOXO3;ZNF23;IRF1;CREB5;KLF11;ZBTB25;HOXB3;NFYA;PLAGL1;ZIC5;ZBTB20;HOXB6;MEOX2;NR4A2;CARF;MYPOP;NR3C1;HNRNPU;TAL1;TEAD3;ZBTB24;KCNIP3;ZNF585B;ZNF585A;CHD2;HDAC1;AHR;NKX2-1;KLF9;TBX18;RBPJ;NR4A1;ZIC4;SOX9;SMAD4;ZNF394;ZNF496;ELK4;RORA;TWIST1;HEY2;FOXL1;RARB;POU2F2;YY1;FOXK2;DNMT3A;RUVBL2;SMAD3;ARNT;FOXP4;SOX1;E2F4;PER1;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2336103025325623,-1.0117053379331515,0.4375,0.7723784548881085,1.0,30/91,21.61%,KIF16B;PLEKHA5;KRIT1;ADAP2;WDR45B;CLVS1;STXBP6;SNX14;SNX3;KCNH1;TTPAL;SNX21;LAPTM4B;SYT7;SYTL2;PFN1;GSN;VILL;SDCBP;LDLRAP1;HIP1;RPH3A;FCHO2;COMMD1;EXOC1;RAB35;KCNQ1;TIRAP;AVIL;OSBPL2
prerank,disordered domain specific binding (GO:0097718),0.465028196297885,1.0080046789744415,0.4528301886792453,1.0,1.0,7/23,17.84%,PPIL1;RB1;NUMA1;CALM2;TP53;KCNA1;SMAD2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5170378381162326,1.0079048528071726,0.4661016949152542,1.0,1.0,5/12,18.35%,CASP8AP2;APAF1;CTSH;BCL2L13;BAD
prerank,beta-tubulin binding (GO:0048487),0.4551951210715117,1.0069267996890323,0.4758539458186101,1.0,1.0,8/31,17.61%,RACGAP1;SMC3;UXT;EMD;TAOK1;EML4;TBCD;TRPV4
prerank,tau-protein kinase activity (GO:0050321),0.4702602431700751,1.0049594438444498,0.44223107569721115,1.0,1.0,5/20,9.82%,DYRK1A;ROCK2;GSK3B;ROCK1;MARK2
prerank,chemokine binding (GO:0019956),0.459890944380133,1.004706435874965,0.45985401459854014,1.0,1.0,6/30,15.02%,PLP2;PDPN;CXCR4;HMGB1;ITGB1;ITGAV
prerank,nucleosomal DNA binding (GO:0031492),0.47228726474120547,1.00248088508288,0.463254593175853,1.0,1.0,13/21,24.83%,SMARCC1;RBBP4;SMARCA4;HDAC1;HDAC2;MBD3;MBD2;CHD4;ACTL6A;H3-3A;SMARCC2;SMARCB1;HNRNPC
prerank,death receptor activity (GO:0005035),-0.39893596153001765,-1.0019573810156603,0.41590214067278286,0.7894127779811692,1.0,4/11,11.61%,TNFRSF19;FAS;TNFRSF11A;TNFRSF1B
prerank,Hsp70 protein binding (GO:0030544),-0.29149344580036335,-1.0006371092558277,0.4968553459119497,0.7863919495208873,1.0,12/31,24.85%,PRKN;DNAJA1;GPR37;PACRG;STUB1;DNAJC18;METTL21A;PPEF2;DNAJB12;RPS3;TSC1;HIKESHI
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.30940578240801003,-1.0000507820367792,0.4427083333333333,0.7811206025348457,1.0,7/25,13.03%,PARP8;TIPARP;ART3;PARP6;PARP1;SIRT5;PARP16
prerank,cadherin binding (GO:0045296),0.4154612168383375,0.9977046325341767,0.511,1.0,1.0,65/315,15.34%,DIAPH3;CIP2A;CCNB2;TMPO;CKAP5;ANLN;CDH15;MACF1;CDH18;CDH24;ANXA2;ZC3HAV1;PARVA;ASAP1;GPRC5A;RAB10;PACSIN2;UBAP2;ARHGAP18;SNX1;SERBP1;MRE11;CDH4;STK24;EIF4H;AFDN;CTNNA1;CNN2;SCRIB;SH3GLB1;LARP1;CORO1B;ABCF3;NCK1;ABI1;EPS8L1;PICALM;EMD;ERC1;MARK2;RAB1A;RANGAP1;TLN1;NDRG1;TWF1;CAPZA1;CRKL;EZR;ANXA1;PDLIM5;TES;WASF2;TJP2;EHD1;BAIAP2L1;CAST;CLIC1;DLG1;TMOD3;ITGB1;CAPG;MPRIP;CLINT1;VAPA;SRC
prerank,poly(A) binding (GO:0008143),0.47165416061389687,0.9963485720187149,0.46540880503144655,1.0,1.0,10/21,15.90%,PABPC4;KHDRBS1;RBMS2;HNRNPU;RBMS3;LARP4;RBMS1;PABPC1;ZC3H14;DDX1
prerank,exopeptidase activity (GO:0008238),-0.25782895550667734,-0.9934971491627869,0.46226415094339623,0.7906302009315398,1.0,12/50,14.51%,LNPEP;CPE;CTSZ;LAP3;ACE;METAP1D;ENPEP;CTSA;DPP9;DPP8;XPNPEP1;PRCP
prerank,GTPase inhibitor activity (GO:0005095),0.49087187351522826,0.9915062092862744,0.4608567208271787,1.0,1.0,4/13,16.58%,IQGAP2;CPEB2;IPO5;TNK2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.44293316659930154,0.9913399618755225,0.49724972497249725,1.0,1.0,14/53,14.88%,AIFM2;DPYD;MTHFR;XDH;MICAL3;AGPS;QSOX1;NOX4;KMO;SQOR;CYBB;GFER;ACADL;CYB5R1
prerank,P-type ion transporter activity (GO:0015662),0.49865243381371716,0.9896620981531287,0.45977011494252873,1.0,1.0,3/12,10.76%,ATP2B4;ATP2A2;ATP2B1
prerank,FAD binding (GO:0071949),0.4658169297190988,0.9845547975449631,0.48905109489051096,1.0,1.0,6/24,9.83%,MTHFR;MICAL3;AGPS;QSOX1;KMO;SQOR
prerank,nuclear receptor coactivator activity (GO:0030374),0.4265504929088477,0.9840486962259052,0.48839779005524864,1.0,1.0,14/52,13.65%,MED14;ACTN4;THRAP3;CCAR1;MED30;ELK1;CNOT6;MED24;NCOA2;PRKCB;SLC30A9;NCOA7;PPRC1;MED1
prerank,retinoic acid receptor binding (GO:0042974),0.48324280688895765,0.9819475407645012,0.4772117962466488,1.0,1.0,7/17,20.22%,CNOT1;ACTN4;ASXL1;NR4A2;MED1;ARID5A;MED25
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.4403598832695408,0.9816807308180107,0.4752714113389626,1.0,1.0,6/29,16.57%,SLC25A21;SLC38A7;SLC19A1;SLC25A30;SLC1A5;SLC25A22
prerank,small GTPase binding (GO:0031267),0.4110752008472693,0.9814810770627975,0.5437185929648242,1.0,1.0,38/169,13.49%,BIRC5;USP6NL;IQGAP2;RANGRF;TRIOBP;EXOC4;EVI5L;MYCBP2;OCRL;MYO1C;AFDN;MLPH;FGD4;BICD2;CDC42EP2;YBX3;RAB29;FGD1;GCC1;ANKRD27;LRRK2;GOLGA5;TBC1D7;PICALM;ERC1;MAPKAP1;RANGAP1;SRGAP2;LSM2;MYO9B;FGD6;NDRG1;RAPGEF4;ABCA1;CHM;RANBP2;EHD1;EXOC8
prerank,GDP binding (GO:0019003),-0.23772872810841245,-0.978879373708717,0.5166666666666667,0.8197630950445095,1.0,17/63,15.27%,RAB28;RAP1A;GNAI1;RAB27B;RAB5B;RERG;RALB;MRAS;RASL12;DYNC1LI1;RAB5A;RAB2A;RIT1;RAP2C;RAB12;RRAGC;ARL8B
prerank,cAMP binding (GO:0030552),-0.38623247644606545,-0.9788603228890179,0.4823529411764706,0.8132169309189219,1.0,5/11,18.60%,HCN1;CNBD2;PDE10A;PDE2A;PDE4D
prerank,alpha-tubulin binding (GO:0043014),0.44415438728433837,0.9786435499295275,0.48398576512455516,1.0,1.0,9/31,20.67%,RACGAP1;SETD2;TRAPPC14;INO80;TAOK1;EML4;TRPV4;DIP2B;SNCA
prerank,ribonuclease P RNA binding (GO:0033204),0.5033269868771864,0.9775394921559177,0.48721804511278194,1.0,1.0,4/10,19.62%,RPP40;RPP30;POP1;RPP21
prerank,growth factor receptor binding (GO:0070851),-0.21883294960051636,-0.9771983818938471,0.6,0.8107430398821315,1.0,24/95,20.57%,IL1R1;PSEN1;VEGFC;SNX4;PDGFRB;PIBF1;FGF2;NCSTN;ERBB4;TGFA;FGF1;GRB2;PDGFD;SNX2;SDCBP;HIP1;SHC1;VEGFA;VEGFB;LINGO1;VEGFD;IL1RAP;HBEGF;ITGB3
prerank,ubiquitin-specific protease binding (GO:1990381),-0.3299193694823843,-0.9771147251670042,0.4541832669322709,0.8046295460638457,1.0,10/19,24.63%,PRKN;DERL1;SELENOS;RHBDD2;SART3;SYVN1;PARK7;RAD23A;CHMP3;SPATA2
prerank,protein phosphatase binding (GO:0019903),0.410849897345423,0.9768350653219176,0.5427698574338086,1.0,1.0,27/117,18.69%,NEK2;MASTL;ATP2B4;ANAPC7;KCNN4;CDC27;MAPT;PDLIM4;RPA2;ANK1;MTMR9;EIF2AK3;AP3B1;AKAP11;ENSA;CDKN1B;PTPA;MTMR3;TP53;ANKLE2;ANAPC5;SIRPA;PPME1;MVP;BAD;MAPK14;KIFAP3
prerank,transferrin receptor binding (GO:1990459),0.5063520738531464,0.9767105924543553,0.49696969696969695,1.0,1.0,3/10,9.79%,RGMA;SNX1;IKBKG
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5064952163603833,0.9764265667418193,0.48343373493975905,1.0,1.0,4/11,10.86%,UBE2K;PRPF19;UBR5;UBOX5
prerank,aspartic-type peptidase activity (GO:0070001),0.505204952091022,0.9760106009992767,0.4764079147640791,1.0,1.0,1/10,2.13%,CTSE
prerank,protein phosphatase 2A binding (GO:0051721),0.45597062956471174,0.9746608571260714,0.49506172839506174,1.0,1.0,7/23,17.38%,MASTL;MAPT;ENSA;PTPA;TP53;ANKLE2;PPME1
prerank,RNA stem-loop binding (GO:0035613),0.4915472676972037,0.9744040135180085,0.48970588235294116,1.0,1.0,6/12,14.58%,DHX9;MYH10;FMR1;RC3H2;RC3H1;EPRS1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.40843508182800103,0.9739501656421383,0.5583501006036218,1.0,1.0,21/173,10.85%,E2F8;EN1;TCFL5;ZFP69;ETV6;SP2;CTCF;ZEB1;BHLHE41;NFIL3;GZF1;ZBTB2;MXD1;FOXO3;ZFP90;ZBTB25;PLAGL1;ZBTB20;MYPOP;NR3C1;KCNIP3
prerank,manganese ion binding (GO:0030145),0.42214136542107533,0.9738056767445717,0.504424778761062,1.0,1.0,9/48,12.44%,LARGE1;B4GALT1;PRIMPOL;TDP2;GALNT1;B4GALT7;PIM1;MPPED2;GYG1
prerank,cardiolipin binding (GO:1901612),0.5052616476477954,0.9715950581626743,0.4945054945054945,1.0,1.0,2/10,14.53%,STOML2;GSDMD
prerank,calcium ion binding (GO:0005509),0.4046027225054318,0.9712650909740573,0.57,1.0,1.0,40/323,12.92%,EFCAB11;MELK;PON1;CDH15;LOXL2;ADGRV1;PLSCR2;SCUBE1;CDH18;CDH24;ANXA9;ANXA2;FBN1;ITPR1;PAM;TPM4;PRNP;CDH4;ANXA3;ANXA5;NDUFAB1;CABCOCO1;ENPP2;HPGDS;PPP3CA;ENPP3;FKBP9;ATP2A2;SLC8A1;TKT;TRPM2;CALM2;ANXA1;ENPP1;CALB1;MICU1;ITPR3;TRPM4;MEX3B;MAN1C1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.4969939716438927,0.9699650146427307,0.4885844748858447,1.0,1.0,3/11,9.16%,MAP3K1;MAP3K20;MAP3K4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4086933670392114,0.968777294457254,0.5468277945619335,1.0,1.0,27/147,12.61%,ECT2;PCP2;RANGRF;DENND2C;FNIP1;RCBTB2;MYCBP2;DENND4C;DNMBP;FGD4;EIF2B1;DENND2A;VAV2;FGD1;ANKRD27;RAB3IL1;FARP1;EPS8L1;RIC8B;DENND5A;HERC2;CYTH3;FGD6;RAPGEF4;ARHGEF18;DENND1A;DOCK11
prerank,metallocarboxypeptidase activity (GO:0004181),0.45230501666901995,0.9683201860055323,0.5093167701863354,1.0,1.0,3/26,6.15%,VASH2;AGBL2;CPXM1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.29965489812891427,-0.9664781739948392,0.4744186046511628,0.8241253537835479,1.0,4/24,4.87%,PLA2G4A;PLEKHA5;CERT1;SNX3
prerank,cGMP binding (GO:0030553),-0.3796211113835745,-0.9636051017015593,0.484472049689441,0.8249335630818346,1.0,9/11,58.21%,PDE10A;PDE2A;PDE11A;CNGB1;CNGB3;RAPGEF2;CNGA2;CNGA4;CNGA3
prerank,SUMO transferase activity (GO:0019789),0.4682831081396583,0.9608453614303193,0.5089163237311386,1.0,1.0,7/16,24.17%,TRIM28;NSMCE2;RANBP2;EGR2;HDAC4;PIAS1;UBE2I
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3542139609587054,-0.9601807534448159,0.4673913043478261,0.8268889577290265,1.0,6/12,18.25%,PIK3R3;PIK3C2B;ATM;PIK3R6;PIK3CD;PIK3CA
prerank,pyrophosphatase activity (GO:0016462),0.41139635472650443,0.9589757685399066,0.5193798449612403,1.0,1.0,13/50,13.60%,DHX9;LHPP;NUDT5;ENPP3;ITPA;PPA1;TRPM2;ENPP1;PLPP1;PLPP5;RNGTT;DXO;NUDT4
prerank,ligand-gated cation channel activity (GO:0099094),-0.22561576263501013,-0.9578371042903675,0.5454545454545454,0.8263876333685106,1.0,20/75,23.70%,GRIK1;GRIN3A;GRIN2A;KCNJ3;GRIN2B;GRIK4;KCNJ6;KCNN2;CHRNA7;GRIA1;KCNJ10;GRIN1;MCOLN1;GRIA2;KCNK1;KCNJ12;GRIK2;P2RX4;KCNN3;PTK2B
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3978904436452572,0.9562404880936547,0.6036036036036037,1.0,1.0,49/254,15.84%,NR2E3;E2F2;MYBL1;E2F3;TFDP1;TFCP2L1;RFXAP;MDM4;NFIA;ZFP62;KLF5;SRF;ELF4;NFIB;HOXC4;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;ELK1;FOXO3;PLAGL2;IRF1;HOXB3;PLAGL1;MEOX2;NR4A2;NR3C1;ZNF585B;ZNF585A;RBPJ;NR4A1;SOX9;SMAD4;ATF5;ELK4;YY1;RLF;FOXK2;SMAD3;E2F4;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;TP53
prerank,NF-kappaB binding (GO:0051059),0.44766266056087,0.953803892445782,0.5138705416116248,1.0,1.0,5/24,12.63%,SETD6;GSK3B;FAF1;HDAC1;HDAC2
prerank,endopeptidase activity (GO:0004175),0.39994245588038174,0.9524653692249149,0.603,1.0,1.0,39/257,14.21%,KEL;ESPL1;CTSE;MMP24;MMP28;MMP25;USP1;SENP1;TRABD2B;CASP7;MMP14;USP18;NLN;USP37;TASP1;ADAMTS10;PLAU;ADAMTS5;ADAMTS14;ADAMTS9;HTRA2;PSMB1;ADAMTSL2;USP16;ADAMTS2;ADAMTS16;TPP2;PSMB9;USP28;ADAM17;CASP8;CTSH;ADAMTSL3;USP9X;USP47;ADAM9;ADAM19;HTRA3;ADAMTS1
prerank,phosphotyrosine residue binding (GO:0001784),-0.2621087658749282,-0.9518740114589829,0.5891472868217055,0.8341143986543744,1.0,11/37,14.54%,PIK3R3;PIK3R1;SHE;BCAR3;IRS1;PFN1;ABL1;GRB2;PTPN11;LDLRAP1;SHC1
prerank,glucuronosyltransferase activity (GO:0015020),0.4566542923191521,0.9518266969283582,0.5013227513227513,1.0,1.0,2/19,6.43%,LARGE1;CHSY1
prerank,voltage-gated anion channel activity (GO:0008308),-0.3297407333651299,-0.9508102809713458,0.5263157894736842,0.8303005676629265,1.0,4/15,9.49%,ANO6;ANO1;GPR89B;GPR89A
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2434689825326346,-0.9503440276258687,0.5238095238095238,0.8251401893907074,1.0,16/49,18.80%,PLCXD3;DUSP11;FRA10AC1;DUSP3;PRUNE1;ENPP6;PTPN22;ACP2;PTPRO;GDPD3;ATP1A2;GDPD1;PPP5C;EPHX2;PPP1CB;ACP6
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3786375725154957,-0.9478891724096113,0.5650793650793651,0.8192614382766259,1.0,7/11,33.40%,SIL1;HSPH1;PFN1;HSPBP1;BAG3;GRPEL1;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.3786375725154957,-0.9478891724096113,0.5650793650793651,0.8192614382766259,1.0,7/11,33.40%,SIL1;HSPH1;PFN1;HSPBP1;BAG3;GRPEL1;BAG2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.40625934974551686,0.9478728349618517,0.542948038176034,1.0,1.0,18/71,17.68%,CDKN3;EYA4;PTPN2;ACP1;CDC25B;CDC25C;CDC25A;EYA2;PTPN21;PTPRS;PTPRA;PTPN13;PTPRU;MTMR3;PTEN;PTPRK;PTPRE;CDC14A
prerank,voltage-gated potassium channel activity (GO:0005249),-0.21947557604503637,-0.947274605709141,0.56,0.8146105860280513,1.0,14/80,13.30%,KCNC2;HCN1;KCNB1;KCNJ3;KCNQ3;KCNH1;KCNJ6;KCNN2;KCNS3;KCNH7;KCNJ10;KCNA6;KCNA2;KCNT1
prerank,protein kinase inhibitor activity (GO:0004860),0.4141423427220479,0.9447371519763155,0.5139977603583427,1.0,1.0,12/42,20.67%,CIT;CEP43;PARVA;NCK1;SPRED1;CDKN1B;QARS1;RPTOR;SPRED2;SH3BP5;TRIB1;SNCA
prerank,tRNA methyltransferase activity (GO:0008175),-0.3277492487584164,-0.9401558811877824,0.5340909090909091,0.8250610888196951,1.0,7/16,35.53%,TRMT9B;THUMPD3;LCMT2;TRMT44;TYW3;TRMT12;BCDIN3D
prerank,hyaluronic acid binding (GO:0005540),-0.39052484458935705,-0.9394400305877679,0.5081081081081081,0.8207360946692812,1.0,7/10,36.54%,CEMIP;LAYN;IMPG2;C1QBP;HYAL2;LYVE1;CHODL
prerank,filamin binding (GO:0031005),0.47556840753477436,0.9388617751173532,0.5242424242424243,1.0,1.0,4/11,12.88%,RFLNA;DPYSL4;DPYSL3;SYNPO2
prerank,RNA binding (GO:0003723),0.3936638503052497,0.9365671510847352,0.794,1.0,1.0,312/1321,18.25%,TOP2A;BRCA1;MKI67;NUSAP1;RAD51AP1;BARD1;KPNA2;ZGRF1;DDX11;HMGB2;RBM15;PNLDC1;ZC3H7A;ILF3;SYNCRIP;SMC1A;NAP1L1;MEX3A;LBR;FLYWCH2;MACF1;SETX;ADK;DEK;MOV10;PABPC4;MYEF2;TRIP6;DGCR8;ROCK2;SREK1;LARP4B;HDGF;AGO2;ANXA2;ZC3HAV1;SRSF4;HNRNPD;TRA2B;CNOT1;BICC1;ALG13;RBFOX2;CSTF3;PATL1;ACTN4;FIP1L1;DNTTIP2;KHDRBS1;PNISR;DNA2;UBAP2;DHX9;PRKDC;DIAPH1;SRBD1;PEG10;HNRNPA1;DDX50;SRF;TNPO1;EIF4E;SRSF10;SARS2;SERBP1;UPF3B;FAM120A;PRPF38B;THRAP3;MAPT;CCAR1;YLPM1;NUDT5;MYH10;LSM3;MBNL3;EIF4ENIF1;RAVER2;EIF4H;SLBP;CTNNA1;HMGN2;G3BP1;EXD1;PSIP1;RBM25;SAMD4A;FNDC3B;CAPRIN1;TPR;NMD3;ERI1;UBE2N;DDX39B;PSPC1;MAP3K20;PRPF40A;FMR1;RRS1;HNRNPH1;TXN;NOSIP;SRSF7;NUCKS1;YBX3;POLR2A;RBMS2;FUS;MEX3C;MATR3;DHX8;RC3H2;DNAJC21;PPIG;RPP40;MRM1;SAP18;CELF2;DARS2;LARP1;TRIM28;TUT1;TUT7;HNRNPUL1;DARS1;PELP1;NQO1;HMGB3;BCLAF1;PPP1R8;WDR33;PRPF3;NOL6;UTP3;MRM3;CPEB2;RBM42;NONO;SF3A2;PUM2;LONP1;MAP4;SRPRA;PRRC2B;HMGB1;MARK2;PCF11;HOXB6;RANGAP1;MRTO4;NOL11;DDX18;LSM2;SCAF8;SRSF3;SFPQ;HNRNPU;FASTKD5;YTHDF2;RBPMS2;TAF15;RARS2;SAMSN1;MRPL13;RBM15B;HNRNPL;SRPK1;SRRM1;CRKL;CPSF4;DHX37;CHD2;RPP30;EZR;GANAB;POP1;ESF1;SNRNP35;FAM32A;HTATSF1;ERH;SUGP2;EXOSC7;HNRNPUL2;COA6;EIF3C;SUMO2;RBMS3;DAP3;HNRNPH2;TSR1;FUBP1;MRPL1;TES;RPS17;SSRP1;HDAC2;NOM1;PPP1CC;ILF2;MEX3B;SIDT1;DUT;TCF20;PPAN;MEX3D;DXO;POLR1G;CAST;PTBP2;TUT4;RBM4;PPRC1;DHFR;DDX21;DDX56;LARP4;NUDT4;LSM7;SRP72;DRG2;DAZAP1;EIF1AX;SMG6;STRBP;YY1;RC3H1;ERI3;WBP4;EIF4A2;HLTF;TRMT2A;RBMS1;PRRC2A;NOL12;PABPC1;SNTB2;MAK16;EPRS1;EWSR1;AQR;LUC7L3;ZC3H14;TFB1M;SECISBP2;KIN;RBM19;HNRNPA2B1;ZC3H7B;FXR1;CKAP4;ADD1;GNL3;ACO1;LSM4;IPO5;HELB;PPIL4;UNK;DDX1;ZCCHC8;NUP42;CNOT4;RBM27;ZC3H18;RCC2;CISD2;LARP1B;PNPT1;TEP1;PURA;RALY;MSN;RPL22L1;AKAP1;METTL3;KHNYN;DENR;STXBP1;DHX38;SRP9;NUP98;MRPS24;UNC50;RBM10;PYM1;HNRNPLL;FCF1;PHF6;BZW1;MRPL45;TPD52L2;EDC3;ZC3H8;ASCC3;EIF3H;ZNF346;USO1;SRPK2;LUC7L2;ABT1;CWC22;MRPL42;PKN2;MRPL37;MRPL2;DDX10;MRPL20;RPL34;BUD13;GPATCH4;DDX59
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.4677935728500552,0.9355412820128229,0.5260115606936416,1.0,1.0,5/13,21.19%,BMP6;BMP2;SRC;BMP3;BMP5
prerank,mRNA binding (GO:0003729),0.392563757499367,0.9337212247535421,0.628,1.0,1.0,69/249,17.42%,TYMS;RBM15;SYNCRIP;PABPC4;MYEF2;LARP4B;AGO2;SRSF4;TRA2B;RBFOX2;CSTF3;KHDRBS1;DHX9;SRBD1;SERBP1;UPF3B;MYH10;EIF4ENIF1;SLBP;G3BP1;RBM25;SAMD4A;TPR;FMR1;YBX3;RBMS2;RC3H2;CELF2;LARP1;TUT1;RNF40;PPP1R8;CPEB2;PUM2;PCF11;SCAF8;HNRNPU;YTHDF2;RBPMS2;MRPL13;HNRNPL;SNRNP35;RBMS3;FUBP1;DXO;PTBP2;RBM4;DHFR;LARP4;DAZAP1;RC3H1;RBMS1;PABPC1;AQR;LUC7L3;SECISBP2;HNRNPA2B1;FXR1;GNL3;ACO1;UNK;TP53;METTL3;KHNYN;DENR;NUP98;ANGEL2;HNRNPLL;EDC3
prerank,store-operated calcium channel activity (GO:0015279),-0.3755378433160503,-0.9329935424696629,0.5304878048780488,0.8304391643164912,1.0,3/10,10.27%,TRPC5;TRPC3;TRPC1
prerank,Toll-like receptor binding (GO:0035325),-0.3723305086755136,-0.9323969832466812,0.5420560747663551,0.8258727334933965,1.0,9/11,48.23%,UNC93B1;TIRAP;TOLLIP;MYD88;CD36;TLR6;TLR1;S100A9;TLR2
prerank,thioesterase binding (GO:0031996),0.48156845879844934,0.9315726704717688,0.5318518518518518,1.0,1.0,5/11,21.78%,HAUS7;RAC1;TRAF6;TRAF2;TRAF4
prerank,cysteine-type peptidase activity (GO:0008234),0.3989338606008827,0.9303538055070929,0.5787278415015641,1.0,1.0,20/73,19.03%,ESPL1;USP1;CASP7;USP18;USP37;USP21;USP16;USP28;CASP8;CTSH;USP9X;USP47;OTUD7B;SFRP1;GGH;USP48;USP14;ATG4C;USP46;USP20
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.24242485502261446,-0.9300806612708813,0.631578947368421,0.8248498000308591,1.0,6/49,3.34%,PLA2G4A;CPNE8;PCLO;MCTP1;ANXA6;SYT1
prerank,snRNA binding (GO:0017069),0.4156090768523954,0.9296775848741128,0.557919621749409,1.0,1.0,12/42,16.60%,COIL;LSM11;DDX39B;TUT1;LSM2;HNRNPU;SNRNP35;SF3B3;DDX21;LSM7;LSM4;PRPF4
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.4001415027640966,0.929130876587624,0.5608180839612487,1.0,1.0,11/55,10.76%,ATP2B4;ANXA9;ANXA2;ITPR1;PKD2L2;CUL5;MCU;ATP2A2;SLC24A3;TRPM2;ATP2B1
prerank,BMP receptor binding (GO:0070700),0.46780686384606934,0.9256352758056944,0.5384615384615384,1.0,1.0,5/12,21.19%,BMP6;BMP2;SRC;BMP3;BMP5
prerank,myosin II binding (GO:0045159),0.48435009149141917,0.9254236024189691,0.5590433482810164,1.0,1.0,3/10,9.30%,TRIOBP;STXBP5;LLGL2
prerank,calcium:sodium antiporter activity (GO:0005432),-0.3886752927122845,-0.9238427842152725,0.5830815709969789,0.8336212212130992,1.0,3/10,5.78%,SLC8A3;SLC24A2;SLC3A2
prerank,protein phosphatase activator activity (GO:0072542),0.45659839534163715,0.9235854397931587,0.5457142857142857,1.0,1.0,6/13,20.14%,PPP2R5C;CALM2;PTPA;PPP2R5B;IGFBP3;PHACTR4
prerank,monocarboxylic acid binding (GO:0033293),0.4369598282308505,0.9232548277447242,0.5203804347826086,1.0,1.0,1/18,3.24%,CYP26B1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4312369454335365,0.9227891153719128,0.5451174289245982,1.0,1.0,6/24,14.74%,AK1;PMVK;PPIP5K1;IP6K2;DTYMK;AK7
prerank,pentosyltransferase activity (GO:0016763),-0.26507783616684916,-0.9226765438554512,0.5309734513274337,0.8301954355859704,1.0,9/36,13.03%,UPP2;PARP8;TIPARP;ART3;PARP6;PARP1;SIRT5;QTRT2;PARP16
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4662216571127722,0.9225809184139289,0.5393759286775631,1.0,1.0,5/12,24.20%,TRIM37;TRAF6;TRAF2;TRAF4;BABAM2
prerank,cholesterol transfer activity (GO:0120020),0.45760361099326785,0.91998971232765,0.5395284327323162,1.0,1.0,1/16,1.29%,GRAMD1C
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4137176762719273,0.9191025957877018,0.5439229843561973,1.0,1.0,1/30,0.69%,BIRC5
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4590427464557201,0.9188826874294199,0.5521739130434783,1.0,1.0,5/13,14.69%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.46894941107638227,0.9175621238138696,0.5542857142857143,1.0,1.0,5/12,19.36%,SLC19A1;SLC25A25;SLC25A42;SLC25A17;SLC25A5
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4641914492491311,0.9173433890779298,0.555878084179971,1.0,1.0,4/12,10.49%,TGFBR3L;BMPR1A;TGFBR3;TGFBR1
prerank,adenylyltransferase activity (GO:0070566),0.4251168690782635,0.91707358790583,0.5660621761658031,1.0,1.0,8/21,20.27%,TENT2;TENT4A;TUT1;PAPOLB;NMNAT1;COASY;GPHN;NMNAT2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4095734751111936,0.9148244317956731,0.5672853828306265,1.0,1.0,12/37,16.28%,CARS2;SARS2;VARS1;DARS2;DARS1;IARS2;TARS2;PARS2;RARS2;EPRS1;QARS1;LARS1
prerank,RNA cap binding (GO:0000339),0.4403317098396161,0.9142434778258308,0.5385694249649369,1.0,1.0,3/16,8.18%,AGO2;EIF4E;LARP1
prerank,cell adhesion mediator activity (GO:0098631),-0.2817603167906175,-0.9137426791610436,0.547945205479452,0.8449954892445917,1.0,8/24,19.11%,BSG;CNTN6;ESAM;BCAM;CNTN2;NTNG1;NEXN;ROBO4
prerank,pyridoxal phosphate binding (GO:0030170),0.4346435409916771,0.9129314672810102,0.5423514538558787,1.0,1.0,6/20,19.93%,PDXK;PYGB;AGXT;ABAT;ACCS;PYGL
prerank,ligand-gated calcium channel activity (GO:0099604),0.4269476606727576,0.9116831872853028,0.5447470817120622,1.0,1.0,6/19,12.53%,ITPR1;RASA3;TRPA1;TRPM2;ITPR3;TRPM4
prerank,actin monomer binding (GO:0003785),-0.29269069290341226,-0.9114761526772867,0.5520361990950227,0.844298975717906,1.0,6/22,16.18%,TMSB4X;NOS3;PFN1;ABL1;TMSB10;MTSS1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.29681561894621755,-0.9113466871704456,0.625615763546798,0.8389514357096016,1.0,9/21,19.39%,AKAP8L;RYR2;AKAP6;GSKIP;AKAP7;ARFGEF2;ARFGEF1;AKAP8;KCNQ1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4511085818218403,0.9105186937612154,0.5663338088445078,1.0,1.0,6/15,15.84%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1;ABHD4
prerank,zinc ion binding (GO:0008270),0.3823464637905137,0.9100359873421882,0.7137137137137137,1.0,1.0,51/293,15.84%,UHRF1;TK1;ACMSD;GLI2;BAZ1B;RASSF1;UPB1;CTCF;ZEB1;ADA;PRIMPOL;LVRN;MDM4;MBD1;PAM;MYCBP2;BLM;SORD;PTGR2;PDXK;ENPP2;SMPDL3A;ENPP3;PHF2;TRIM28;KDM2B;ZFYVE1;USP16;CDA;DUSP12;APIP;KMT2A;CXXC5;TRHDE;LIMS1;ENPP1;CALB1;ZDHHC15;TES;SEC24D;RC3H1;SMPD1;KDM5C;SMAD3;CA2;EPRS1;RBAK;NPEPPS;KAT6A;LANCL1;TP53
prerank,peptide hormone receptor binding (GO:0051428),-0.37095254177553133,-0.9092582940135285,0.5407166123778502,0.8376093080322994,1.0,4/11,34.40%,PSMC5;PTHLH;ADCYAP1;GNRH1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.38962597152895523,0.9088468754860959,0.6206896551724138,1.0,1.0,18/78,19.03%,ESPL1;USP1;CASP7;USP18;USP37;CAPN15;USP16;USP28;CASP8;CTSH;USP9X;USP47;CAPN5;SFRP1;USP48;USP14;USP46;USP20
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.2873661749674554,-0.907509603031338,0.5550239234449761,0.8361750050700824,1.0,5/21,25.13%,GLRB;CHRNA7;GRIK2;P2RX4;P2RX7
prerank,kinase activity (GO:0016301),0.38500642715893474,0.9072498783379433,0.6408952187182095,1.0,1.0,29/109,17.98%,MASTL;MAP4K4;GSK3B;PMVK;PDXK;IPMK;EPHA4;PAPSS2;LRRK2;FN3K;PPIP5K1;PIK3CB;IP6K2;DGKE;SEPHS1;PANK4;AGK;PKMYT1;PRKD1;PANK2;MVK;TAOK1;TRRAP;STK39;RFK;GK5;PI4KB;GK;PKN2
prerank,inward rectifier potassium channel activity (GO:0005242),-0.27754171639349196,-0.9055472573753488,0.559322033898305,0.8350185399006825,1.0,10/24,30.84%,KCNJ3;KCNJ6;KCNN2;KCNJ10;KCNK1;KCNJ12;KCNN3;ABCC9;KCNJ8;KCNJ15
prerank,epidermal growth factor receptor binding (GO:0005154),-0.2768264674555042,-0.9054966995083465,0.5863874345549738,0.8295874621096899,1.0,9/25,20.19%,SNX4;ERBB4;TGFA;GRB2;SNX2;HIP1;SHC1;LINGO1;HBEGF
prerank,diacylglycerol kinase activity (GO:0004143),-0.3555774663872878,-0.9050577674876996,0.5233644859813084,0.8249250375368143,1.0,6/11,24.52%,DGKB;DGKG;DGKI;DGKQ;DGKD;DGKK
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.29477787653242804,-0.9027583308205964,0.5770925110132159,0.8243915700649951,1.0,6/20,15.02%,SLC39A10;SLC39A13;SLC39A7;SLC30A1;SLC30A4;SLC39A1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.3208290899644821,-0.9019021031213704,0.5650557620817844,0.8209574086394048,1.0,5/17,29.15%,SLC2A1;SLC2A3;SLC2A10;SLC5A11;SLC5A3
prerank,neuropeptide receptor binding (GO:0071855),0.44111981815309037,0.9007424682230516,0.5652777777777778,1.0,1.0,1/14,3.51%,AGRP
prerank,sterol transfer activity (GO:0120015),0.43963681704531743,0.900614517213997,0.553763440860215,1.0,1.0,1/17,1.29%,GRAMD1C
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.4708801271000207,0.896731628071991,0.5905044510385756,1.0,1.0,2/10,9.84%,NOX4;CYBB
prerank,GTPase binding (GO:0051020),0.3763666977817598,0.895852857508632,0.7038152610441767,1.0,1.0,41/194,14.61%,BIRC5;USP6NL;IQGAP2;RANGRF;TRIOBP;EXOC4;EVI5L;MYCBP2;OCRL;MYO1C;AFDN;MLPH;FGD4;BICD2;CDC42EP2;STOML2;YBX3;RAB29;FGD1;GCC1;ANKRD27;LRRK2;GOLGA5;TBC1D7;PICALM;ERC1;MAPKAP1;RANGAP1;SRGAP2;LSM2;MYO9B;FGD6;NDRG1;RAPGEF4;ABCA1;CHM;RANBP2;EHD1;EXOC8;EPRS1;DOCK7
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.47556316699997925,0.8950225310541041,0.5969924812030075,1.0,1.0,4/10,22.22%,PML;ANKRD13D;DNAJB2;DAXX
prerank,growth factor activity (GO:0008083),-0.21482855486882116,-0.8944501150211333,0.6956521739130435,0.8314918798414577,1.0,18/74,24.36%,NRG3;VEGFC;JAG1;FGF2;IGF2;TGFA;GRN;FGF1;VEGFA;JAG2;VEGFB;INHBA;VEGFD;CSPG5;HBEGF;BDNF;FGF10;FGF7
prerank,nuclear receptor binding (GO:0016922),0.3734726137039682,0.8933724716544846,0.6526207605344296,1.0,1.0,34/111,20.25%,TRIP6;CNOT1;MED14;ACTN4;ASXL1;THRAP3;LCOR;TCF7L2;MED30;ARID1A;MED24;SMARCA4;ZNHIT3;NR4A2;MMS19;NCOA2;GRIP1;PRKCB;TRIP12;NR4A1;NCOA7;PPID;MED1;SMAD3;JMJD1C;DCAF1;BRD8;TAF10;FOXP1;ARID5A;MED16;GTF2B;MED25;RNF14
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.46334204050705974,0.8912381922818865,0.5862573099415205,1.0,1.0,4/11,17.44%,SLC19A1;SLC25A25;SLC25A42;SLC25A17
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.38572768381542627,0.890354380829587,0.6006749156355455,1.0,1.0,12/49,18.57%,RAD18;ZRANB3;RNF168;UIMC1;AGAP3;IKBKG;BRCC3;OTUD7B;RNF169;RAD23B;EPS15;ZBTB1
prerank,outward rectifier potassium channel activity (GO:0015271),0.4613243294378396,0.8898204930844564,0.5689404934687954,1.0,1.0,3/11,16.36%,KCNK2;PKD2;KCNT2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.39093555933745905,0.8896049342534876,0.5719339622641509,1.0,1.0,18/35,25.43%,AGO2;POU2F1;SMARCA4;NR3C1;GTF2A1;HDAC1;TAF4;RUVBL2;DR1;TP53;DRAP1;FOXP1;GTF2B;UBTF;H3-3A;SMARCB1;RELA;BAZ2A
prerank,TBP-class protein binding (GO:0017025),0.42153301155282247,0.8893876846348906,0.5545796737766625,1.0,1.0,10/21,21.66%,PSMC2;TAF12;GTF2A1;AHR;RUVBL2;YEATS2;DR1;DRAP1;GTF2B;GTF2A2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.33714814674391547,-0.889376083507218,0.5614617940199336,0.8367725119886544,1.0,5/13,31.58%,SREBF2;ECH1;IDI1;MIF;EBP
prerank,ubiquitin protein ligase binding (GO:0031625),0.37237324987060294,0.8888938530680716,0.728,1.0,1.0,37/254,11.41%,BRCA1;UBE2T;RAD18;SMC6;TRIM37;RB1;TRIOBP;GSK3B;UBE2K;GPI;NLK;CHEK2;FAF1;RPA2;SLF1;CXCR4;FANCL;ARRB1;PML;FBXW7;UBE2N;CUL5;POLR2A;RNF31;TRIM28;RNF40;MFN2;SMAD6;CUL3;AXIN2;CUL4B;PSMD1;IKBKG;HERC2;UBOX5;ARRDC1;BAG5
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.29356008900297714,-0.8873226511989608,0.6046511627906976,0.8305353857517314,1.0,7/17,27.95%,EPHA5;EPHB2;EPHA8;EFNB3;EPHB4;EPHA2;EPHB3
prerank,ephrin receptor activity (GO:0005003),-0.29356008900297714,-0.8873226511989608,0.6046511627906976,0.8305353857517314,1.0,7/17,27.95%,EPHA5;EPHB2;EPHA8;EFNB3;EPHB4;EPHA2;EPHB3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4117631508087132,0.8872649238936766,0.5708860759493671,1.0,1.0,6/22,15.46%,ZRANB3;RNF168;UIMC1;IKBKG;OTUD7B;RNF169
prerank,NAD binding (GO:0051287),0.4115082554611553,0.8868737860735215,0.5659203980099502,1.0,1.0,5/26,10.40%,ZC3HAV1;CTBP1;SORD;ALDH1A1;PARP9
prerank,nucleotide diphosphatase activity (GO:0004551),-0.3167650347777935,-0.8868155257068957,0.6236933797909407,0.8263257202399391,1.0,6/14,22.66%,FHIT;NUDT3;ENPP4;ENPP5;NUDT6;NUDT12
prerank,active ion transmembrane transporter activity (GO:0022853),-0.23850498672924444,-0.8862828671440183,0.6883116883116883,0.8222526331352614,1.0,7/37,8.12%,SLCO1C1;SLC22A8;SLCO2B1;COX4I1;COX5A;SLCO2A1;SLC22A6
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4403819405883619,0.884553970783628,0.579092159559835,1.0,1.0,3/14,9.84%,NOX4;KMO;CYBB
prerank,steroid hydroxylase activity (GO:0008395),0.435206194510588,0.8844079498417616,0.5798898071625345,1.0,1.0,1/16,2.74%,CYP39A1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.30865607749694435,-0.8840175480426427,0.5951417004048583,0.8218549789406902,1.0,6/15,18.25%,PIK3R3;PIK3C2B;ATM;PI4KA;PIK3CD;PIK3CA
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.358778608372197,-0.8835125349142491,0.5977011494252874,0.8178874143887708,1.0,4/10,8.12%,SLCO1C1;SLCO2B1;SLCO2A1;SLC22A6
prerank,1-phosphatidylinositol binding (GO:0005545),0.4372988268299856,0.8834109640381865,0.5704125177809388,1.0,1.0,8/15,22.51%,SESTD1;ZFYVE16;ZFYVE1;PICALM;ZFYVE9;SNAP91;EEA1;SNX9
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4392458174991773,0.8824563602579433,0.5835694050991501,1.0,1.0,3/14,14.74%,AK1;DTYMK;AK7
prerank,androgen receptor binding (GO:0050681),-0.27328749533473407,-0.8822408527263731,0.6407766990291263,0.8155709940986187,1.0,8/25,20.33%,EP300;PRPF6;PRMT2;KDM4C;DDX5;TGFB1I1;PARK7;SNW1
prerank,palmitoyltransferase activity (GO:0016409),-0.2675760909595479,-0.8821415349076908,0.6633165829145728,0.8107709210100633,1.0,11/28,23.28%,GLUL;ZDHHC5;ZDHHC1;ZDHHC13;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC16;ZDHHC20;ZDHHC4;ZDHHC17
prerank,calcium channel inhibitor activity (GO:0019855),0.4407639344850504,0.8820624357471469,0.5749636098981077,1.0,1.0,3/11,10.94%,ITPR1;MCUB;CALM2
prerank,transition metal ion binding (GO:0046914),0.369397472506808,0.8809701984067076,0.81,1.0,1.0,65/397,15.51%,UHRF1;TK1;ACMSD;GLI2;LOXL3;LOXL2;BAZ1B;RASSF1;UPB1;CTCF;ZEB1;LARGE1;B4GALT1;ADA;PRIMPOL;LVRN;MDM4;MBD1;PAM;MYCBP2;TDP2;GALNT1;BLM;PRNP;SORD;PTGR2;PDXK;ENPP2;AGMO;SMPDL3A;ENPP3;PHF2;B4GALT7;TRIM28;KDM2B;SOD3;TYR;ZFYVE1;USP16;CDA;DUSP12;PIM1;MPPED2;APIP;KMT2A;CXXC5;TRHDE;LIMS1;ENPP1;CALB1;COA6;ZDHHC15;GYG1;TES;SEC24D;RC3H1;SMPD1;KDM5C;SMAD3;CA2;EPRS1;RBAK;NPEPPS;KAT6A;LANCL1
prerank,R-SMAD binding (GO:0070412),0.4284361795085861,0.880603689733037,0.5791610284167794,1.0,1.0,7/18,19.39%,PMEPA1;SMAD6;SMURF1;SMAD4;SMAD3;SMAD2;PPM1A
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.45437350281408784,0.8799490597613497,0.6075581395348837,1.0,1.0,1/13,2.38%,GPSM2
prerank,alkali metal ion binding (GO:0031420),0.43641416590723786,0.8794463180175541,0.5926928281461434,1.0,1.0,3/13,10.91%,PDXK;ACAT1;DRG1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.2551386612959203,-0.8793664164675159,0.6546762589928058,0.8114475459486584,1.0,21/35,37.12%,TRMT9B;DTWD2;PUS10;AARS1;QTRT2;PTRH2;QTRT1;NT5C3A;LCMT2;DTWD1;ALKBH1;DUS3L;ELAC2;QRSL1;MRPL58;GATC;TYW3;TRMT12;BCDIN3D;TRPT1;DUS2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.2923226805019964,-0.8791956958185414,0.5867768595041323,0.8069009825101188,1.0,10/19,29.61%,NRG3;GAS6;GRM5;DGKQ;AFAP1L2;EFNA5;EGF;ERBB3;PAK2;CD24
prerank,endoribonuclease activity (GO:0004521),-0.24794299863447278,-0.8784273216458529,0.7032258064516129,0.8036780082573314,1.0,13/32,27.69%,AGO1;AGO3;NYNRIN;DICER1;RIDA;ENDOV;ZC3H12A;EXOG;NOB1;TSNAX;RNASEL;INTS11;ZC3H12B
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.4488782003658016,0.8762875016707888,0.5863052781740371,1.0,1.0,6/12,24.56%,FXN;XDH;CISD2;ISCA2;SDHB;CIAPIN1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.3657413322912242,-0.8747735020196207,0.6196721311475409,0.8061438816986707,1.0,2/10,15.78%,SLC6A1;SLC6A11
prerank,metalloaminopeptidase activity (GO:0070006),0.4215298507513964,0.8737138234852146,0.5690376569037657,1.0,1.0,4/16,15.07%,MMP14;LVRN;TRHDE;NPEPPS
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4210976499233683,0.8727353526579633,0.601418439716312,1.0,1.0,2/14,14.11%,CAPN15;CAPN5
prerank,phosphoric diester hydrolase activity (GO:0008081),0.39266220571352295,0.8716753776990306,0.6273148148148148,1.0,1.0,12/35,18.27%,APEX2;TDP2;ENPP2;SMPDL3A;ENPP3;MPPED2;ENPP1;SMPD1;PLCB4;SMPD3;GDE1;SMPD2
prerank,MAP kinase phosphatase activity (GO:0033549),-0.3223096538101243,-0.869535044780611,0.631578947368421,0.8116717138633576,1.0,4/12,28.16%,DUSP3;DUSP1;DUSP8;DUSP6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.42478840515953753,0.8657673358343345,0.5804597701149425,1.0,1.0,4/14,17.42%,MINDY4;USP9X;OTUD7B;MINDY3
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3254700437096293,-0.8641844750560043,0.6067796610169491,0.8174066889421571,1.0,5/14,15.85%,SLC1A2;SLC25A13;SLC25A12;SLC17A6;SLC1A1
prerank,heme binding (GO:0020037),0.368275262702789,0.859000379161459,0.651564185544768,1.0,1.0,12/65,18.40%,DGCR8;CYP26B1;PTGES2;NOX4;PGRMC2;CYBB;CYB5B;HCCS;SRC;CYB5A;THAP4;PTGIS
prerank,RNA polymerase II complex binding (GO:0000993),0.38928496202626683,0.8570956372161194,0.6183745583038869,1.0,1.0,8/32,12.86%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;RPRD1A;BRD4
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.2923422652745746,-0.8522530082467671,0.6987951807228916,0.8359666332841406,1.0,5/17,25.11%,ACOT11;PPT1;ACOT7;ACOT13;ACOT6
prerank,GABA receptor binding (GO:0050811),0.4278797813116341,0.8512765419939133,0.605301914580265,1.0,1.0,1/11,3.22%,TRAK1
prerank,N-acyltransferase activity (GO:0016410),0.39071142676377074,0.8512007687357945,0.6243961352657005,1.0,1.0,3/32,3.20%,NAT14;CERS6;CERS5
prerank,5'-3' RNA polymerase activity (GO:0034062),0.39746041131059023,0.8510473256072886,0.6178660049627791,1.0,1.0,4/27,7.48%,TENT2;POLR1A;POLR1B;POLR2A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.3418289079008727,-0.8505561988637924,0.6553846153846153,0.8340828430656623,1.0,2/11,20.20%,DDAH2;PADI2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.36400514716603555,0.8448716169783459,0.6804670912951167,1.0,1.0,6/70,6.43%,HAS3;HYAL1;LARGE1;B4GALT1;B3GNT8;CHSY1
prerank,metalloexopeptidase activity (GO:0008235),0.369514290889492,0.8445358912563773,0.6681564245810055,1.0,1.0,11/51,18.10%,VASH2;MMP14;LVRN;AGBL2;CPXM1;CPQ;TRHDE;NPEPPS;AGTPBP1;METAP1;DPEP1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.31002169232227306,-0.8395177525865516,0.6462093862815884,0.8503733564575423,1.0,5/15,15.85%,SLC1A2;SLC25A13;SLC25A12;SLC17A6;SLC1A1
prerank,glycerophospholipid flippase activity (GO:0140333),0.43709112114694854,0.83933041644875,0.6566091954022989,1.0,1.0,2/11,4.58%,ABCA4;ABCB4
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.24652132550132683,-0.8385763306751162,0.7341772151898734,0.8471931836610631,1.0,10/32,23.52%,SLC6A6;SFXN2;SLC3A2;SLC7A5;SLC1A1;SLC38A5;SLC25A38;SFXN3;SLC36A1;SLC6A7
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.34885206260584645,0.836196221394679,0.7748743718592965,1.0,1.0,31/181,14.44%,RBL1;SETD6;RB1;MIER1;RBBP8;GSK3B;DDRGK1;ACTN4;DHX9;BHLHE41;FAF1;MKKS;TCF7L2;ARID1A;ELK1;SMARCA4;MIER3;MTA3;PARP9;TAL1;TEAD3;NCOA2;HDAC1;TAF4;RBPJ;HDAC2;NCOA7;HEY2;MED1;SMAD3;ARNT
prerank,ribosomal small subunit binding (GO:0043024),0.4075427016789658,0.8295021732091973,0.6361221779548473,1.0,1.0,4/17,9.43%,EIF4H;LARP1;CPEB2;PIM1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.42372102858859506,0.8279100689376806,0.6417910447761194,1.0,1.0,3/10,16.85%,B4GALT1;B4GALT7;B3GALT2
prerank,I-SMAD binding (GO:0070411),0.4130307920763534,0.8272169147705994,0.6269727403156384,1.0,1.0,6/13,17.84%,SMAD6;SMURF1;TGFBR1;SMAD4;SMAD3;SMAD2
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3201257680299632,-0.8254455461882426,0.72,0.8671715420235514,1.0,2/12,14.38%,SLC2A1;SLC2A3
prerank,RNA polymerase core enzyme binding (GO:0043175),0.37591170467454926,0.8252213832502436,0.6481700118063755,1.0,1.0,8/33,12.68%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;SPTY2D1;RPRD1A
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3618787397600429,0.8243524294478368,0.6769406392694064,1.0,1.0,11/42,17.31%,ANXA2;RAB10;DSCAML1;DSCAM;ANXA1;EMB;PDLIM5;BAIAP2L1;TMOD3;SIRPA;CD47
prerank,mRNA 5'-UTR binding (GO:0048027),0.3912050368371222,0.8223784461196407,0.6619897959183674,1.0,1.0,4/24,8.18%,SYNCRIP;MYH10;FMR1;LARP1
prerank,carboxypeptidase activity (GO:0004180),0.376414252298223,0.8218700571545549,0.6733490566037735,1.0,1.0,4/35,9.16%,VASH2;AGBL2;CPXM1;SCPEP1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3867368103773323,0.8214482700963311,0.639686684073107,1.0,1.0,5/20,14.69%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1
prerank,ATPase regulator activity (GO:0060590),-0.23544919260731326,-0.8195794583369527,0.7857142857142857,0.872726408669761,1.0,8/38,10.63%,ATP1B1;DNAJC24;DNAJC19;SIL1;DNAJA1;HSPH1;ATP1B3;PFN1
prerank,phosphatidylinositol binding (GO:0035091),0.3459994042059027,0.8158820720365887,0.7258726899383984,1.0,1.0,30/91,22.51%,ITPR1;NUMA1;SNX1;PARD3B;MAPT;SESTD1;ZFYVE16;ZFYVE1;PICALM;SNX27;PITPNB;PIGU;AIDA;APPL2;ITPR3;DENND1A;MITD1;EXOC8;C2CD2L;PASK;PLEKHF2;ZFYVE9;DPEP1;SNAP91;EEA1;MYO1E;GPAA1;APPL1;PHF12;SNX9
prerank,receptor ligand activity (GO:0048018),0.3409695241031856,0.8148369495275555,0.841,1.0,1.0,16/245,11.42%,TNFSF13B;HMGB2;ARTN;ERFE;WNT2B;BMP6;IL18;INSL6;FAM3C;SFRP2;WNT6;HMGB1;AGT;EDA;CNTF;BMP2
prerank,transcription coactivator binding (GO:0001223),0.3911689742761924,0.8147413180352162,0.6567164179104478,1.0,1.0,5/20,14.35%,CIT;AHR;SMAD4;RORA;SMAD3
prerank,gap junction channel activity (GO:0005243),0.38994114555039483,0.8143955434340059,0.6553030303030303,1.0,1.0,3/22,12.36%,GJD3;GJC1;GJA1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.42812702987867346,0.8140152631662694,0.6666666666666666,1.0,1.0,5/10,24.95%,SIRPA;CD47;DSG2;CXADR;CD200
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3915801929851679,0.8111069727315301,0.657608695652174,1.0,1.0,4/17,16.40%,AK1;DTYMK;AK7;NOL9
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3849464416963062,0.8078406440782036,0.6587615283267457,1.0,1.0,4/18,10.49%,TGFBR3L;BMPR1A;TGFBR3;TGFBR1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3638212479860457,0.8067238439487996,0.6914285714285714,1.0,1.0,8/38,12.31%,SPAG9;FRS2;LRRK2;NCK1;MMS19;GRIP1;MAPK8IP3;NCK2
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3285584146364289,-0.806600317168077,0.7541899441340782,0.8903024983082987,1.0,4/10,22.03%,ANO6;ANO1;CLCN2;CLCN4
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.4061407681028293,0.8064468349530258,0.6796116504854369,1.0,1.0,5/14,18.35%,CASP8AP2;APAF1;CTSH;BCL2L13;BAD
prerank,wide pore channel activity (GO:0022829),0.3841954894740446,0.804831486611123,0.664572864321608,1.0,1.0,3/23,12.36%,GJD3;GJC1;GJA1
prerank,DNA-binding transcription factor binding (GO:0140297),0.3376690596790613,0.8037312218823185,0.8251256281407036,1.0,1.0,41/189,19.43%,RBL1;CBX5;RB1;MIER1;RBBP8;GSK3B;DDRGK1;DHX9;FHL2;BHLHE41;SRF;EIF4E;CTBP1;MKKS;TCF7L2;ELK1;MIER3;YAP1;HMGB1;MTA3;CXXC5;TAL1;RUNX1T1;TEAD3;HDAC1;RBPJ;HDAC2;TWIST1;HEY2;TLE4;SMAD3;TLE3;TP53;PURA;RERE;SMAD2;EGR2;RBL2;ZFPM2;SKI;ZFPM1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.32247278304435373,-0.8024041055485697,0.7090395480225988,0.8923612023031983,1.0,4/11,29.15%,SLC2A10;SLC5A11;SLC2A9;SLC5A3
prerank,neuropeptide hormone activity (GO:0005184),0.37022687701759677,0.80215267968008,0.6670807453416149,1.0,1.0,1/22,3.51%,AGRP
prerank,acid-thiol ligase activity (GO:0016878),0.3995944250843342,0.7986626073828975,0.6992805755395683,1.0,1.0,2/13,14.02%,ACSS1;AACS
prerank,translation elongation factor activity (GO:0003746),-0.29616914433226393,-0.7986136950561613,0.7649122807017544,0.8939466286853708,1.0,5/14,25.03%,EEF1A1;EEF2;EEF1B2;TSFM;EIF5A2
prerank,potassium ion leak channel activity (GO:0022841),0.38464729324526736,0.7979769968044627,0.6635135135135135,1.0,1.0,3/15,12.54%,KCNK2;KCNK12;KCNK6
prerank,tRNA binding (GO:0000049),-0.21074013329387434,-0.7947686786845325,0.8648648648648649,0.895398349714157,1.0,16/43,30.19%,EEF1A1;TRMT9B;AARS1;NSUN2;SARS1;DALRD3;TRMT10B;KARS1;TRMT10A;IGHMBP2;RPUSD4;ALKBH1;YARS2;PTCD1;YRDC;XPOT
prerank,endopeptidase activator activity (GO:0061133),0.4116799923984914,0.7946307132348834,0.6756756756756757,1.0,1.0,3/10,20.45%,PSMD14;ADRM1;PSME3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.41297613687535395,0.7925556781206368,0.6779141104294478,1.0,1.0,2/10,12.76%,CASP7;CASP8
prerank,cyclic nucleotide binding (GO:0030551),-0.25675141074800123,-0.7921006937717713,0.799163179916318,0.8948054411230894,1.0,6/21,18.60%,HCN1;KCNH1;CNBD2;PDE10A;PDE2A;PDE4D
prerank,ribonuclease activity (GO:0004540),0.3341977686461376,0.7900511770999591,0.7217962760131434,1.0,1.0,12/56,16.48%,AGO2;RNASE6;RNASEH2A;RPP40;CNOT6;PPP1R8;RNASE1;EXOSC7;RNASE12;SMG6;CNOT7;KHNYN
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.39591172684088993,0.7876023774155411,0.6837016574585635,1.0,1.0,4/15,15.59%,SETD3;KMT2A;KMT2D;SETD4
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3041408807796595,-0.7866114369208239,0.7191358024691358,0.898926413640993,1.0,2/12,5.78%,SLC6A6;SLC3A2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.36734554472813663,0.785127697020427,0.6900129701686122,1.0,1.0,4/22,13.11%,ILF3;CPEB2;RBMS3;MEX3D
prerank,NADP binding (GO:0050661),0.35983978778037184,0.7845991092002726,0.7196702002355713,1.0,1.0,8/32,19.53%,GMDS;LBR;DPYD;TM7SF2;DHFR;DHCR7;CRYZL1;ME3
prerank,muscle alpha-actinin binding (GO:0051371),0.3867685961571042,0.7825174947207995,0.7072829131652661,1.0,1.0,4/15,15.61%,PDLIM4;PDLIM5;SYNPO2;PKD2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3517317418402941,0.7824563795633617,0.6981351981351981,1.0,1.0,11/33,21.26%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;RPRD1A;DRAP1;RPRD1B;GTF2B;SMYD2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.40227417530498577,0.7816212242018605,0.6887905604719764,1.0,1.0,3/11,12.14%,ITPR1;TRPC7;ITPR3
prerank,myosin V binding (GO:0031489),-0.27777492323879266,-0.7815101938510477,0.7509157509157509,0.902023607653074,1.0,8/15,28.43%,RAB6B;RAB27B;RAB11A;RAB39B;RAB3D;RAB6A;RAB3B;RAB14
prerank,calcium activated cation channel activity (GO:0005227),0.38280419811350586,0.7807373397502334,0.7255689424364123,1.0,1.0,5/17,14.80%,KCNN4;KCNMB2;KCNMB3;TRPM4;KCNMB4
prerank,hexosyltransferase activity (GO:0016758),0.3277747215756133,0.7749510989673871,0.7782340862422998,1.0,1.0,12/101,12.44%,POMT1;HAS3;HYAL1;LARGE1;B4GALT1;B3GNT8;CHSY1;B4GALT7;HAS1;POFUT1;TMTC4;GYG1
prerank,cation transmembrane transporter activity (GO:0008324),0.33708772253270786,0.7744989971365315,0.7341490545050056,1.0,1.0,10/48,18.43%,SLC25A15;SLC38A7;SLC25A2;SLC38A9;SLC15A4;SLC1A5;SLC36A4;SLC7A1;SLC6A9;SLC38A2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.39178005883125894,0.7720186742430305,0.6994134897360704,1.0,1.0,3/11,24.64%,SLC25A47;SLC25A29;SLC22A4
prerank,endopeptidase inhibitor activity (GO:0004866),0.32375901717438216,0.7691909522190362,0.7797494780793319,1.0,1.0,7/82,9.78%,SERPINB8;SERPINA9;ANXA2;PRNP;SERPINE1;ROCK1;AGT
prerank,aminopeptidase activity (GO:0004177),0.3497024538548351,0.767776961283218,0.7098765432098766,1.0,1.0,6/26,18.01%,MMP14;LVRN;TRHDE;CTSH;NPEPPS;METAP1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.39677559801901424,0.764253914469655,0.7321156773211568,1.0,1.0,1/10,2.69%,ECHDC3
prerank,anion transmembrane transporter activity (GO:0008509),0.3855153069397357,0.764129801132805,0.7224606580829757,1.0,1.0,3/12,10.75%,SLC19A1;SLC4A2;SLC39A8
prerank,G protein-coupled receptor binding (GO:0001664),-0.16801400450814305,-0.763301722014991,1.0,0.9257642275626388,1.0,24/132,17.54%,PRKN;GNAI1;GNA12;HOMER1;BICD1;ARHGEF12;GNAL;DNAJA1;ITGB4;GNA14;ACE;GPRASP2;PACRG;AGTR1;PSMC5;STUB1;PTCH1;TAFA5;SDCBP;S1PR1;DVL1;LRP6;USP33;PICK1
prerank,Tat protein binding (GO:0030957),-0.31124052739751007,-0.7628170916451766,0.7764705882352941,0.9213974683235997,1.0,2/10,7.57%,ACTB;DNAJA1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.3904534623162025,0.7620987458522264,0.7094972067039106,1.0,1.0,5/12,19.29%,SULF2;SULF1;ARSB;ARSI;ARSG
prerank,general transcription initiation factor binding (GO:0140296),0.35384946831530717,0.7616879086542102,0.7230392156862745,1.0,1.0,8/25,16.12%,PSMC2;TAF12;GTF2A1;AHR;RUVBL2;YEATS2;DR1;DRAP1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3622136385516768,0.7616017966961661,0.7319316688567674,1.0,1.0,6/18,17.84%,TGFBR3L;TGFBR3;SMAD6;TGFBR1;SMAD3;SMAD2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.39346820346878153,0.758691537173214,0.7209985315712188,1.0,1.0,5/12,19.95%,PDE3B;PDE7B;PDE7A;PDE4B;PDE4A
prerank,neurexin family protein binding (GO:0042043),0.39981359279078016,0.7583346560163852,0.7170111287758346,1.0,1.0,4/10,19.52%,NLGN3;SYTL4;NLGN2;SYTL5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.33143663238262944,0.7564948426397486,0.7656078860898138,1.0,1.0,17/54,22.44%,MIER1;UPB1;DARS1;NADSYN1;MIER3;HDAC8;HINT1;HDAC1;ASRGL1;HDAC2;NTAN1;NTAQ1;ASPA;HDAC4;NAAA;SIRT2;MIER2
prerank,phosphatase activity (GO:0016791),0.3269835550426946,0.7544390633204381,0.7966280295047419,1.0,1.0,10/73,14.03%,PON1;LHPP;OCRL;LPIN2;PHOSPHO2;DUSP12;PLPP1;PLPP5;PPP1CC;ARMT1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.3894678792988352,0.7543637053624402,0.7360482654600302,1.0,1.0,2/11,12.76%,CASP7;CASP8
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.37680467743554147,0.7513883552160606,0.7276536312849162,1.0,1.0,4/14,18.08%,MTHFR;PYCR1;DHFR;BLVRB
prerank,snoRNA binding (GO:0030515),0.3445936723741553,0.7511612871556919,0.7426829268292683,1.0,1.0,6/30,13.60%,PRKDC;NUDT5;DHX37;TSR1;DDX21;NUDT4
prerank,potassium:proton antiporter activity (GO:0015386),0.39289547737324215,0.7500780551532169,0.7361769352290679,1.0,1.0,1/10,8.60%,SLC9A5
prerank,hormone activity (GO:0005179),0.3271154845970357,0.7492308902027197,0.7699784017278618,1.0,1.0,4/54,9.78%,AGRP;ERFE;INSL6;AGT
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.3551497380367194,0.7481094197892714,0.7338709677419355,1.0,1.0,8/20,25.17%,SENP1;USP21;USP9X;USP47;EIF3H;COPS5;USP25;UFSP2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.31689338964649777,0.7474556290236861,0.8166838311019567,1.0,1.0,17/100,14.55%,RACGAP1;IQGAP2;ARFIP1;GBF1;MAPT;SESTD1;ZFYVE16;ZFYVE1;OSBPL8;SNX27;MAPKAP1;CYTH3;CLVS2;DENND1A;BTK;GSDMD;ATG2A
prerank,translation initiation factor activity (GO:0003743),0.3258465006597927,0.7438507847407044,0.7488317757009346,1.0,1.0,13/36,22.93%,AGO2;EIF4E;EIF2B1;EIF3C;EIF4A2;MTIF3;EIF3H;EIF3I;EIF2D;COPS5;EIF5;EIF2B5;EIF3B
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.3889319601595843,0.7429187190831108,0.7253731343283583,1.0,1.0,2/11,9.30%,PIGN;PTDSS2
prerank,MAP kinase activity (GO:0004707),0.3631899951448797,0.7424421759918142,0.7203994293865906,1.0,1.0,2/14,4.01%,NLK;MAPK4
prerank,phosphatidic acid binding (GO:0070300),0.34775251687418407,0.7411870683511353,0.7161803713527851,1.0,1.0,7/19,22.24%,PACSIN2;SESTD1;MAPKAP1;GSDMD;SMPD3;GRAMD1B;RAPGEF6
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3211296374310304,0.7410291934831836,0.7844638949671773,1.0,1.0,9/51,13.37%,SLCO4A1;SLC20A2;SLC35D1;SLC16A10;SLC35D2;SLC16A2;MCU;SLC25A30;SLCO3A1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3373413128957242,0.7369833684941346,0.7595238095238095,1.0,1.0,7/29,20.71%,PPM1D;TPR;MAPKAPK3;MAPK14;DUSP7;ATF7;MAPKAPK2
prerank,sodium channel regulator activity (GO:0017080),0.3286338135196164,0.7353254244983077,0.7827626918536009,1.0,1.0,3/37,4.42%,ATP2B4;RANGRF;NEDD4
prerank,potassium channel activity (GO:0005267),0.3092529292795565,0.733987426649648,0.8238341968911918,1.0,1.0,16/89,17.09%,AQP1;CCDC51;KCNN4;KCNK2;KCNH4;KCNH8;GRIK3;KCNMB2;KCNMB3;KCNK12;KCNK6;KCNMB4;KCNB2;PKD2;KCNT2;KCNA1
prerank,syntaxin-1 binding (GO:0017075),-0.24235427238331075,-0.733274482184497,0.8471074380165289,0.9589180328960974,1.0,8/22,17.59%,UNC13B;SYT1;SYNPR;SNPH;CPLX1;VAMP3;SNAP25;SYPL1
prerank,galactosyltransferase activity (GO:0008378),0.3727505963662867,0.7323445242231484,0.7635829662261381,1.0,1.0,2/11,7.98%,B4GALT1;B4GALT7
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.37323184918976743,0.7323403424644886,0.7631954350927247,1.0,1.0,5/13,17.33%,GSK3B;EZR;SOX9;PRKAR2B;PRKAR2A
prerank,sterol binding (GO:0032934),0.31611413798796684,0.731731931498602,0.7826552462526767,1.0,1.0,17/56,20.91%,GRAMD1C;TSPO2;SOAT1;OSBPL8;SCAP;ABCA1;SOAT2;SIDT1;RORA;VDAC2;STARD3;SYP;ERLIN1;INSIG2;GRAMD1B;TSPO;INSIG1
prerank,protease binding (GO:0002020),0.3054538175183595,0.7278737704523175,0.8561001042752867,1.0,1.0,19/99,16.98%,BRCA2;FADD;ANXA9;GSK3B;ANXA2;PRNP;LCOR;DERL2;SERPINE1;RIOK3;BDKRB2;ADRM1;INSL3;ITGB1;ITGAV;TP53;STIM1;PTEN;LDLR
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.1942588589851525,-0.7270556007303778,0.9083969465648855,0.962059178188312,1.0,13/40,23.84%,PCMTD2;PCMTD1;HNMT;THUMPD3;N6AMT1;TPMT;NNMT;PRMT8;RRP8;METTL9;MEPCE;SUV39H1;COMT
prerank,ribosome binding (GO:0043022),0.3201415886793295,0.7268845851934136,0.7953281423804227,1.0,1.0,13/46,19.36%,SERBP1;ERI1;EFL1;FMR1;NCLN;CPEB2;EIF3C;SRP72;MAIP1;PYM1;MTIF3;ETF1;CCDC47
prerank,death domain binding (GO:0070513),-0.28760750593511086,-0.7261719810868452,0.8157099697885196,0.9581724261694518,1.0,6/11,21.90%,CRADD;BCL2;IRGM;DAPL1;BCL2L1;RACK1
prerank,CoA-ligase activity (GO:0016405),0.3550733406218133,0.7252008372130588,0.7303988995873453,1.0,1.0,2/14,14.02%,ACSS1;AACS
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.36066254437634676,0.7245727224800326,0.7562408223201175,1.0,1.0,4/13,18.20%,SLC38A7;SLC15A4;SLC7A1;SLC25A29
prerank,GTP binding (GO:0005525),0.3063916262341616,0.7245535654509877,0.8916750250752257,1.0,1.0,35/172,18.23%,RANBP17;TUBB6;TUBA1C;TUBE1;RHOA;RAB10;RRAD;RHOT1;RAP2A;ATL2;ATL3;RAB22A;RAB29;RASEF;TUBD1;LRRK2;RHOQ;DNM2;DRG1;RND2;RAC1;RRAS;SEPHS1;TSR1;DRG2;ARF4;ARL4A;RHOC;GNL3;ARF3;RRAS2;RAB13;NRAS;KRAS;ARL5A
prerank,protein kinase C activity (GO:0004697),0.35902739060777966,0.7235686633834737,0.7547683923705722,1.0,1.0,7/14,21.01%,PRKCB;PRKCA;PRKCE;PRKD1;PRKCI;PRKCD;PRKD3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.22571671026686813,-0.7205850484082812,0.8592964824120602,0.9602339432241711,1.0,8/23,29.20%,PLCB3;PLCG1;CHRM3;PLCE1;PLCH1;PLCD1;PLCB1;PLCD3
prerank,guanyl ribonucleotide binding (GO:0032561),0.30392447032447795,0.7184694518684932,0.925777331995988,1.0,1.0,39/196,18.23%,RANBP17;TUBB6;TUBA1C;TUBE1;RHOA;RAB10;RRAD;RHOT1;RAP2A;SLC19A1;ATL2;ATL3;RAB22A;RAB29;RASEF;TUBD1;LRRK2;RHOQ;DNM2;MPPED2;MIEF1;DRG1;RND2;RAC1;RRAS;SEPHS1;TSR1;GNAI3;DRG2;ARF4;ARL4A;RHOC;GNL3;ARF3;RRAS2;RAB13;NRAS;KRAS;ARL5A
prerank,cholesterol binding (GO:0015485),0.31136960152167165,0.7130619486916389,0.7918050941306756,1.0,1.0,11/47,16.62%,GRAMD1C;TSPO2;SOAT1;OSBPL8;ABCA1;SOAT2;SIDT1;VDAC2;STARD3;SYP;ERLIN1
prerank,potassium channel regulator activity (GO:0015459),0.31209562461170376,0.7112761664117146,0.7991071428571429,1.0,1.0,12/49,19.35%,WNK1;KCNMB2;KCNMB3;KCNIP3;AKAP9;ADRB2;ENSA;DLG1;KCNMB4;DPP6;WNK3;AMIGO1
prerank,mannosyltransferase activity (GO:0000030),0.3325742109093176,0.7107980062670908,0.7819843342036553,1.0,1.0,4/21,15.83%,POMT1;TMTC4;ALG8;PIGM
prerank,anion:anion antiporter activity (GO:0015301),0.33623893945066774,0.7088012569000814,0.774365821094793,1.0,1.0,2/17,8.21%,SLC19A1;SLC4A2
prerank,chemoattractant activity (GO:0042056),0.32175440548966305,0.7067669467916823,0.7620253164556962,1.0,1.0,1/26,1.44%,HMGB2
prerank,frizzled binding (GO:0005109),0.3243764907836221,0.7001746025686244,0.7860520094562647,1.0,1.0,6/34,19.06%,WNT2B;RNF43;WNT6;WNT9A;SFRP1;WNT4
prerank,double-stranded RNA binding (GO:0003725),0.30417367181446575,0.7000269953364554,0.8408376963350785,1.0,1.0,15/70,17.56%,ILF3;DGCR8;AGO2;DHX9;EIF4H;FMR1;RC3H2;HNRNPU;ILF2;SIDT1;STRBP;RC3H1;FXR1;MSN;ZNF346
prerank,deubiquitinase activity (GO:0101005),0.2958996444805676,0.6999861490720223,0.8388773388773388,1.0,1.0,26/88,22.62%,MINDY4;USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;USP9X;USP47;BRCC3;OTUD1;OTUD7B;USP48;MINDY3;EIF3H;USP14;USP46;USP20;PAN2;OTUD3;COPS5;TANK;ZRANB1;USP2;MYSM1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.36287732858444105,0.6996507063502992,0.8023774145616642,1.0,1.0,1/11,3.44%,MAP4K2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3606795409172482,0.698962325332718,0.767616191904048,1.0,1.0,4/12,26.72%,SLC9A5;LETM1;SLC9B2;SLC9A8
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3035926156251091,0.6984415843495856,0.8146128680479825,1.0,1.0,11/53,18.43%,SLC25A15;SLC38A7;SLC25A2;SLC38A9;SLC15A4;SLC1A5;SLC25A22;SLC36A4;SLC7A1;SLC6A9;SLC38A2
prerank,protein phosphatase regulator activity (GO:0019888),0.3003179778941146,0.6958085300188184,0.8200654307524536,1.0,1.0,17/53,21.36%,PPP2R3A;PPP1R7;PPP2R5C;CALM2;PPP2R2D;ENSA;PPP1R15B;PTPA;PPP2R5B;PPP2R1B;ANKLE2;PPME1;PPP6R2;BOD1L1;PHACTR4;PPP4R1;EIF2AK2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.32861327778594485,0.6927282421561748,0.794344473007712,1.0,1.0,2/21,12.04%,ANXA9;CHRNB1
prerank,mannose binding (GO:0005537),-0.2791997749565688,-0.6908689227767775,0.8910891089108911,0.9887395486096185,1.0,8/12,53.49%,CLN5;LMAN2L;LMAN2;LMAN1;ACR;COLEC11;LMAN1L;CLEC4D
prerank,phospholipase C activity (GO:0004629),-0.2099966189880933,-0.6883799975933008,0.9382022471910112,0.9862042201822148,1.0,8/25,29.20%,PLCB3;PLCG1;CHRM3;PLCE1;PLCH1;PLCD1;PLCB1;PLCD3
prerank,alpha-actinin binding (GO:0051393),0.3187093930782856,0.6854937333458987,0.7888748419721872,1.0,1.0,5/24,15.61%,PDLIM4;CACNA1C;PDLIM5;SYNPO2;PKD2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3585338653327278,0.6853814372936794,0.817910447761194,1.0,1.0,3/10,18.10%,DPYSL4;DPYSL3;DPEP1
prerank,clathrin adaptor activity (GO:0035615),0.33690706823299177,0.6848709870480263,0.8011049723756906,1.0,1.0,2/15,5.98%,STON1;STON2
prerank,proton transmembrane transporter activity (GO:0015078),-0.18748927560627687,-0.6822322068357967,0.9527027027027027,0.9877299299708056,1.0,15/39,34.22%,COX4I1;COX5A;NDUFA4;UQCR10;UQCRQ;CLCN4;COX8A;UQCRC1;COX5B;CTNS;ATP6V1B2;UQCRFS1;ATP6V1F;SLC9A1;COX6B1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.209317682831122,-0.681116037325187,0.9261083743842364,0.9835865883523364,1.0,11/26,31.84%,PPP1R1A;SET;PPP1R11;PPP1R14A;PABIR1;MGAT5;PPP1R14B;BOD1;SAG;STYXL1;CABIN1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.2678204170240658,-0.6801119810113528,0.8297872340425532,0.9796936917110893,1.0,5/11,29.08%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1;PPP1R14B
prerank,GTPase activity (GO:0003924),0.284713490983127,0.678087635953075,0.9359359359359359,1.0,1.0,32/192,15.76%,RAB33B;RHOA;GNG8;ABCA4;RHOT1;RAP2A;ATL2;EFL1;ATL3;GNA13;RAB22A;RAB29;AGAP3;LRRK2;MFN2;GNAQ;RHOQ;DNM2;TPPP;SRPRA;RAB1A;DRG1;RND2;RAC1;RRAS;TSR1;GNAI3;DRG2;GNG5;GFM2;RHOC;MFN1
prerank,potassium ion antiporter activity (GO:0022821),0.3327591242108713,0.6773198916624181,0.801980198019802,1.0,1.0,2/15,9.39%,SLC9A5;SLC24A3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.21663141708235215,-0.6765106134285035,0.9464285714285714,0.9781982321563837,1.0,8/24,23.28%,GLUL;ZDHHC1;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC20;ZDHHC4;ZDHHC17
prerank,serine-type endopeptidase activity (GO:0004252),-0.16140849590988113,-0.6759644568042532,1.0,0.9736947976971633,1.0,11/80,21.38%,PCSK5;PIK3IP1;PCSK6;FURIN;PARL;MMP2;RHBDF1;PRSS12;PCSK1;FAP;RHBDF2
prerank,ribosomal large subunit binding (GO:0043023),0.34237594293604123,0.6740664526130405,0.8210678210678211,1.0,1.0,2/11,9.15%,NMD3;CPEB2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3124241601298166,0.6723187043768191,0.8141592920353983,1.0,1.0,3/25,9.80%,CYP26B1;MICAL3;KMO
prerank,phospholipase binding (GO:0043274),0.3378269620623965,0.6719710760575183,0.8028571428571428,1.0,1.0,7/13,25.64%,ARHGAP6;PDPK1;BTK;SRC;FYN;BLNK;PAFAH1B1
prerank,sodium:proton antiporter activity (GO:0015385),0.3483588613921859,0.6715292429053498,0.8091603053435115,1.0,1.0,1/11,8.60%,SLC9A5
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.3391500847404433,0.6701017547153685,0.8208092485549133,1.0,1.0,12/12,66.11%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW3;OPN1MW;RRH;GPR52;GPR88;OPN3
prerank,N-acetyltransferase activity (GO:0008080),0.3165302659654634,0.6686347363715304,0.8141711229946524,1.0,1.0,1/19,1.96%,NAT14
prerank,NAD+ binding (GO:0070403),0.3403232235909567,0.6661132157027766,0.8264705882352941,1.0,1.0,2/12,10.40%,ZC3HAV1;PARP9
prerank,hydro-lyase activity (GO:0016836),0.29471887115498085,0.665252804322676,0.8395480225988701,1.0,1.0,7/41,16.59%,GMDS;ECHDC3;PCBD2;APIP;CA2;ACO1;ECI1
prerank,sulfotransferase activity (GO:0008146),0.2998125236170299,0.663909762650948,0.8381839348079162,1.0,1.0,4/33,10.91%,CHST15;CHST3;UST;HS2ST1
prerank,O-methyltransferase activity (GO:0008171),-0.2591111754834591,-0.6617211598407958,0.8828828828828829,0.9819959850030157,1.0,4/10,23.84%,COQ3;CMTR1;MEPCE;COMT
prerank,exoribonuclease activity (GO:0004532),0.3284165288311729,0.658820394711427,0.8621700879765396,1.0,1.0,4/12,18.37%,CNOT6;EXOSC7;CNOT7;EXOSC10
prerank,organic anion transmembrane transporter activity (GO:0008514),0.27440526124071724,0.6581911422509742,0.9200404858299596,1.0,1.0,24/134,18.43%,SLC25A15;SLC25A21;SLCO4A1;SLC38A7;PDPN;SLC19A1;SLC25A2;SLC35D1;SLC25A25;SLC35D2;SLC39A8;GJA1;SLC38A9;SLCO3A1;SLC19A2;SLC15A4;SLC1A5;SLC25A42;SLC25A22;SLC36A4;SLC7A1;SLC25A17;SLC6A9;SLC38A2
prerank,lipoprotein particle binding (GO:0071813),0.31560954181681317,0.6560779722853661,0.8372703412073491,1.0,1.0,4/20,16.98%,COLEC12;MAPT;LPL;LDLR
prerank,carboxylic ester hydrolase activity (GO:0052689),0.28179588967077374,0.6554042908422012,0.8884254431699687,1.0,1.0,14/85,17.54%,PON1;ENPP2;BCHE;TARS2;ACHE;DAGLB;APMAP;CA2;PON2;LPL;ABHD4;NOTUM;GDE1;PNPLA7
prerank,sialyltransferase activity (GO:0008373),0.31067514035630517,0.6528847443901935,0.8295302013422818,1.0,1.0,6/20,15.47%,ST8SIA2;ST3GAL3;ST3GAL5;ST3GAL4;ST3GAL1;ST3GAL2
prerank,semaphorin receptor activity (GO:0017154),0.3342994926242129,0.6522099348096193,0.8451327433628318,1.0,1.0,6/11,23.45%,PLXNB2;PLXNB1;PLXND1;PLXNA2;PLXNB3;PLXNA1
prerank,triglyceride lipase activity (GO:0004806),-0.21564821959348826,-0.6482034232718615,0.940677966101695,0.9880875271058042,1.0,6/20,31.15%,ABHD5;PLA2G15;PNPLA2;PNPLA3;LIPE;DDHD2
prerank,acetylcholine receptor activity (GO:0015464),0.3069890337230511,0.6443608644615012,0.8480204342273308,1.0,1.0,2/22,12.04%,ANXA9;CHRNB1
prerank,ferrous iron binding (GO:0008198),0.3017694237443702,0.6407480418357221,0.8538163001293662,1.0,1.0,2/21,3.92%,FXN;FTO
prerank,ion channel inhibitor activity (GO:0008200),0.28562287299188815,0.6403522394838953,0.8700834326579261,1.0,1.0,7/35,13.53%,ITPR1;NEDD4;WNK1;KCNMB2;MCUB;CALM2;ENSA
prerank,ADP binding (GO:0043531),0.29929343897219607,0.6394834576536607,0.8395522388059702,1.0,1.0,6/25,15.30%,MYH10;LONP1;MYO9B;MIEF1;MSH6;PRKAG1
prerank,phosphatidate phosphatase activity (GO:0008195),0.32419351132139623,0.6371882888994255,0.8456189151599444,1.0,1.0,3/13,12.32%,LPIN2;PLPP1;PLPP5
prerank,methyltransferase activity (GO:0008168),0.27428076944686625,0.6348117783930818,0.8678815489749431,1.0,1.0,10/46,17.47%,METTL27;AMT;EEF1AKMT2;MGMT;ASMT;METTL4;ARMT1;MRM2;METTL3;NSUN3
prerank,omega peptidase activity (GO:0008242),0.268854225620544,0.6326386904697359,0.9132706374085684,1.0,1.0,28/89,23.72%,USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;ASRGL1;USP9X;USP47;BRCC3;OTUD1;OTUD7B;GGH;USP48;MINDY3;USP14;USP46;USP20;PAN2;OTUD3;COPS5;TANK;ZRANB1;USP2;MYSM1;APEH;USP25
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.27718025817110137,0.6304119228293589,0.8725910064239829,1.0,1.0,9/60,9.99%,FGFR4;FGFR2;KIT;MUSK;PDGFRA;CRIM1;EPHA4;FGFRL1;DDR2
prerank,Wnt-activated receptor activity (GO:0042813),-0.2304598221918034,-0.6301449275119251,0.9442379182156134,0.9966979848409866,1.0,5/15,26.81%,FZD2;FZD4;FZD1;TSPAN12;FZD8
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.32454048577522376,0.6295378618368059,0.8628048780487805,1.0,1.0,3/10,16.43%,SETDB2;ASH1L;SUV39H2
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.2201135951573982,-0.6289598301937698,0.9664179104477612,0.9926025796276999,1.0,2/16,12.60%,SLC44A1;SLC22A5
prerank,amino acid transmembrane transporter activity (GO:0015171),0.27447466896152706,0.626743121583208,0.8631221719457014,1.0,1.0,13/47,21.73%,SLC38A7;PDPN;SLC38A4;SLC16A2;SLC38A9;SLC1A5;SLC36A4;SLC7A1;SLC25A29;SLC38A2;SLC25A44;SLC7A11;SLC6A13
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2660570416999218,0.6261616399051321,0.90625,1.0,1.0,24/83,22.62%,USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;USP9X;USP47;BRCC3;OTUD1;OTUD7B;USP48;MINDY3;USP14;USP46;USP20;PAN2;OTUD3;COPS5;TANK;ZRANB1;USP2;MYSM1
prerank,metal ion:proton antiporter activity (GO:0051139),0.31676363955770137,0.6240805378573295,0.8369723435225619,1.0,1.0,4/13,26.72%,SLC9A5;LETM1;SLC9B2;SLC9A8
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.22528995244059052,-0.6165824672432838,0.932475884244373,0.9959068606949762,1.0,5/14,33.58%,SLC26A11;SLC25A11;SLC26A2;SLC26A6;SLC26A8
prerank,ephrin receptor binding (GO:0046875),0.2940199441203863,0.6159856879888239,0.8681022880215343,1.0,1.0,8/21,23.75%,EFNA1;EFNB1;ANKS1B;EFNB2;SRC;PTPN1;FYN;CRK
prerank,phosphatidylcholine transporter activity (GO:0008525),0.2974996201560491,0.609143667845678,0.8764940239043825,1.0,1.0,3/17,11.79%,ABCB4;PITPNB;ABCA1
prerank,NADPH binding (GO:0070402),0.30886382022358055,0.6079910086582957,0.8848821081830791,1.0,1.0,1/13,2.57%,LBR
prerank,G protein-coupled receptor activity (GO:0004930),0.25472499030404205,0.6078049086627114,0.982,1.0,1.0,24/239,16.37%,GPR171;LPAR3;ADGRV1;LPAR1;GALR1;NPFFR2;ADGRL1;GPR173;CXCR4;BDKRB2;NPR3;TAPT1;P2RY1;S1PR2;GLP2R;ADGRG2;ADRB2;GPR156;ELOVL4;LANCL1;GABBR2;CYSLTR2;ADGRD1;GPR135
prerank,estrogen receptor binding (GO:0030331),0.2759096314461741,0.6073031188879264,0.8945497630331753,1.0,1.0,7/32,16.11%,CNOT1;LCOR;MMS19;PPID;MED1;DCAF1;TAF10
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2734328776901642,0.6042960010182176,0.8922155688622755,1.0,1.0,6/30,17.02%,SLC25A37;SLC39A11;SLC39A8;SLC39A6;SLC30A10;SLC25A28
prerank,cation channel activity (GO:0005261),0.25503276421623194,0.6032782219248299,0.9463917525773196,1.0,1.0,20/94,20.23%,AQP1;ANXA9;ANXA2;TRPA1;PKD2L2;CUL5;CALHM2;MCU;SLC24A3;TRPM2;PIEZO1;TRPM4;PKD2;KCNA1;TRPV4;KCNQ4;TRPM6;TMEM63A;KCNK5;PIEZO2
prerank,serine-type peptidase activity (GO:0008236),-0.13788813206215036,-0.6019691992108229,1.0,1.0,1.0,12/96,21.38%,PCSK5;PIK3IP1;PCSK6;FURIN;TPP1;PARL;MMP2;RHBDF1;PRSS12;PCSK1;FAP;RHBDF2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2743277984767642,0.6006644170604776,0.8968058968058968,1.0,1.0,7/24,20.71%,MYLK3;PHKA2;CAMK1D;MAPKAPK3;CAMKV;DAPK1;MAPKAPK2
prerank,protein phosphorylated amino acid binding (GO:0045309),0.26131578043372755,0.6001931456886264,0.8928974069898534,1.0,1.0,11/42,20.50%,NEDD4;FBXW7;VAV2;SAMSN1;CRKL;NCK2;PIN1;SHB;YES1;PTPN5;SHF
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3066238127382753,0.6000955059585645,0.8631875881523272,1.0,1.0,5/12,24.26%,PHF2;JMJD1C;KDM4B;HR;KDM1A
prerank,FMN binding (GO:0010181),-0.23304930928639758,-0.5987166687242932,0.9263803680981595,0.9972415235879283,1.0,8/11,46.16%,NOS3;MTRR;NOS1;NDOR1;DUS2;PNPO;POR;NOS2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.2879870637182308,0.5976772695223513,0.8796414852752881,1.0,1.0,6/21,19.95%,PDE3B;PDE7B;PDE1A;PDE7A;PDE4B;PDE4A
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.2874929941212233,0.5958009504971551,0.896457765667575,1.0,1.0,4/16,16.57%,SLC38A7;SLC25A30;SLC1A5;SLC25A22
prerank,transforming growth factor beta binding (GO:0050431),0.2767244253939434,0.5954227888460518,0.8973042362002568,1.0,1.0,4/23,15.02%,TGFBR3L;TGFBR3;TGFBR1;ITGAV
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.31596439812207827,0.5938381391499299,0.8947368421052632,1.0,1.0,4/10,17.33%,PKIG;PRKAG1;PRKAR2B;PRKAR2A
prerank,phosphatase inhibitor activity (GO:0019212),0.28244848216198104,0.5926702186162245,0.8943298969072165,1.0,1.0,5/20,19.61%,ANP32E;ENSA;PPME1;STYX;BOD1L1
prerank,Hsp90 protein binding (GO:0051879),0.2657929588040136,0.5874688145790572,0.9087677725118484,1.0,1.0,5/33,13.27%,MAPT;HDAC8;NR3C1;AHR;PPID
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.2663965503902185,0.585575647381514,0.9098873591989988,1.0,1.0,3/27,9.73%,SLC9A5;SLC8A1;CNNM4
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.29577444769341965,0.5843473483196122,0.914327917282127,1.0,1.0,2/11,13.60%,NUDT5;NUDT4
prerank,O-acyltransferase activity (GO:0008374),0.263459447069857,0.5834735149023857,0.8916967509025271,1.0,1.0,3/30,12.03%,LPCAT1;SOAT1;SOAT2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.27358343569368637,0.571768758102149,0.898989898989899,1.0,1.0,7/23,22.15%,PDE3B;PDE7B;PDE1A;PDE7A;PDE4B;PDE4A;ADPRM
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.24324989034871453,0.5715263981722608,0.9424686192468619,1.0,1.0,17/74,19.10%,ADK;PDXK;IPMK;PAPSS2;PIK3CB;DGKE;PANK4;AGK;PANK2;MVK;RFK;NOL9;GK5;PI4KB;GK;GALK2;COASY
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.2950053201419108,0.5713891743025531,0.8945783132530121,1.0,1.0,3/10,21.65%,KDM2B;KDM4B;KDM2A
prerank,glutathione transferase activity (GO:0004364),0.2653164397360696,0.5668308060825843,0.9033457249070632,1.0,1.0,6/23,22.12%,HPGDS;LANCL1;GSTT1;MGST3;GSTM5;GSTZ1
prerank,adrenergic receptor binding (GO:0031690),0.27771461387459667,0.5667809222816422,0.9071332436069987,1.0,1.0,1/16,4.42%,NEDD4
prerank,histone demethylase activity (GO:0032452),0.2610638899272586,0.5664786812001206,0.9159347553324969,1.0,1.0,9/27,25.24%,PHF2;KDM2B;KDM5C;JMJD1C;KDM4B;KDM2A;HR;KDM1A;KDM5A
prerank,solute:sodium symporter activity (GO:0015370),0.25886256430005655,0.5632547329289354,0.915129151291513,1.0,1.0,1/27,4.10%,SLC20A2
prerank,RNA methyltransferase activity (GO:0008173),0.26660237923032143,0.5616305537937863,0.9176788124156545,1.0,1.0,8/19,27.82%,METTL4;METTL8;MRM2;METTL3;TGS1;TRMT5;TRDMT1;TRMT13
prerank,transaminase activity (GO:0008483),0.2859650161473439,0.5591180975947679,0.9074889867841409,1.0,1.0,2/11,10.10%,AGXT;ABAT
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.2398698503234079,0.5579971802677985,0.9401330376940134,1.0,1.0,10/55,18.43%,SLC38A7;PDPN;SLC38A4;SLC19A1;SLC16A2;SLC38A9;SLC19A2;SLC36A4;SLC7A1;SLC38A2
prerank,calcium channel activity (GO:0005262),0.23481396701712037,0.5550968073013999,0.9480249480249481,1.0,1.0,15/84,16.39%,ANXA9;ANXA2;CACNA2D3;PKD2L2;CUL5;MCU;SLC24A3;CACNA1C;TRPM2;TRPC7;TRPM4;ITGAV;PKD2;CACNB4;TPCN2
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.22457650099862853,-0.5508767128994453,0.9513677811550152,1.0,1.0,5/10,33.00%,NAA25;NAA80;NAA30;NAA16;NAA10
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.22913116975601994,-0.5472947860820687,0.9648562300319489,1.0,1.0,3/10,16.95%,CACNA1B;CACNB2;CACNB1
prerank,low-density lipoprotein particle binding (GO:0030169),0.2687696037192222,0.5464074509171092,0.9313186813186813,1.0,1.0,1/16,3.25%,COLEC12
prerank,SH2 domain binding (GO:0042169),0.24785833799602133,0.5461694827733887,0.9497005988023952,1.0,1.0,6/31,17.61%,NLK;KHDRBS1;AFAP1;SRC;SH3PXD2B;TRPV4
prerank,N-methyltransferase activity (GO:0008170),0.2546871498212403,0.5437428862487685,0.9470899470899471,1.0,1.0,4/20,14.98%,SETD3;METTL15;METTL5;TFB1M
prerank,cytokine activity (GO:0005125),0.22825980209055136,0.5422464189484666,0.9776195320447609,1.0,1.0,10/131,12.52%,CKLF;WNT2B;BMP6;IL18;FAM3C;WNT6;HMGB1;CNTF;BMP2;WNT9A
prerank,nucleoside-diphosphatase activity (GO:0017110),0.26847379043768904,0.5421301573007621,0.9363507779349364,1.0,1.0,2/12,16.45%,NUDT5;SLC25A42
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.27814713363319293,0.53720821009736,0.9293078055964654,1.0,1.0,1/12,5.14%,B3GNT8
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.24329517154223113,0.5365420442658653,0.9562043795620438,1.0,1.0,1/29,1.97%,HPSE
prerank,C-C chemokine receptor activity (GO:0016493),0.2522369786182037,0.5337587219073117,0.9450830140485313,1.0,1.0,1/21,6.31%,CXCR4
prerank,tropomyosin binding (GO:0005523),0.26880797085795793,0.5325953274315142,0.9374149659863945,1.0,1.0,5/16,22.29%,TMOD3;TNNT3;TMOD1;LMOD1;TMOD2
prerank,peptidase activator activity (GO:0016504),0.2523857160613826,0.5324216847130646,0.9351145038167938,1.0,1.0,6/22,21.09%,CASP8AP2;PSMD14;ADRM1;PSME4;PSME3;TANK
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.23212949994942833,0.52784682603693,0.9619686800894854,1.0,1.0,3/46,6.07%,LARGE1;B3GNT8;PIGA
prerank,phosphatidylglycerol binding (GO:1901611),0.2646664748985733,0.5265951930748298,0.9382352941176471,1.0,1.0,2/13,14.53%,STOML2;GSDMD
prerank,cytochrome-c oxidase activity (GO:0004129),-0.19246686420610987,-0.5264385672381103,0.9757785467128027,1.0,1.0,5/15,24.09%,COX4I1;COX5A;NDUFA4;COX8A;COX5B
prerank,endopeptidase regulator activity (GO:0061135),0.2306031333530913,0.5241147065847284,0.9542857142857143,1.0,1.0,10/40,24.05%,PSMD14;ADRM1;CAST;USP14;PROS1;PSME3;TFPI;RECK;PSMF1;ITIH2
prerank,cytokine receptor binding (GO:0005126),0.22267344094967015,0.5232019343005121,0.9782383419689119,1.0,1.0,12/83,20.28%,FADD;TRIP6;IL18;TGFBR3;CNTF;ADAM17;SPRED1;SMAD3;SPRED2;SMAD2;TYK2;TRAF6
prerank,iron ion binding (GO:0005506),0.22862060391026912,0.523021402484307,0.9599555061179088,1.0,1.0,4/48,7.91%,FXN;FTO;AGMO;PHF2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.20452658854275074,-0.5205984123036265,0.9876543209876543,1.0,1.0,3/10,28.16%,DUSP1;DUSP8;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.20452658854275074,-0.5205984123036265,0.9876543209876543,1.0,1.0,3/10,28.16%,DUSP1;DUSP8;DUSP6
prerank,antiporter activity (GO:0015297),0.24113972678286,0.5195216634232878,0.9238845144356955,1.0,1.0,3/20,13.12%,SLC35D1;SLC35D2;SLC25A30
prerank,chemokine activity (GO:0008009),0.23715557546385257,0.5182265255664577,0.9584816132858838,1.0,1.0,1/31,4.99%,CKLF
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.22688535942090668,0.5158200617005873,0.9619450317124736,1.0,1.0,10/72,14.61%,ANXA9;ANXA2;SESTD1;PICALM;MAPKAP1;TWF1;SNX18;SVIL;GSDMD;CAPG
prerank,rRNA binding (GO:0019843),0.22570355507319095,0.5078863422719995,0.9729425028184893,1.0,1.0,6/42,13.58%,MRPL18;ERI1;RRS1;FASTKD5;PPAN;DDX21
prerank,AMP binding (GO:0016208),0.261774190180408,0.5055222665007567,0.95355587808418,1.0,1.0,4/11,22.88%,MPPED2;PRKAG1;PYGL;PRKAG3
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.25979076221287206,0.5026885715791026,0.9437869822485208,1.0,1.0,1/11,12.04%,CHRNB1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.23324453153561697,0.5009352941240571,0.9712140175219024,1.0,1.0,2/26,6.43%,B3GNT8;CHSY1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.24821042054734002,0.49884080377628176,0.941944847605225,1.0,1.0,1/12,5.79%,FRS2
prerank,mechanosensitive ion channel activity (GO:0008381),0.25084966689374466,0.4961468069359995,0.9643916913946587,1.0,1.0,3/12,20.23%,PIEZO1;TMEM63A;PIEZO2
prerank,phosphate ion binding (GO:0042301),-0.2062386242390008,-0.49580950795416673,0.9872611464968153,1.0,1.0,10/10,79.40%,RPH3A;PDE2A;ADSS1;CHST14;SLC34A2;G6PC1;MTHFD2;RELA;PNP;ADSS2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.22781389606661787,0.4956387762748446,0.972520908004779,1.0,1.0,7/31,21.57%,AQP1;PKD2;KCNA1;KCNQ4;KCNK5;SLC12A8;KCNC4
prerank,chemokine receptor binding (GO:0042379),0.22406618795880395,0.49070004199846823,0.9682352941176471,1.0,1.0,2/35,12.85%,CKLF;ITCH
prerank,C-C chemokine binding (GO:0019957),0.22915712556774115,0.4851797383905622,0.969270166453265,1.0,1.0,1/22,6.31%,CXCR4
prerank,CXCR chemokine receptor binding (GO:0045236),0.24826534215501178,0.4813357901293231,0.9553571428571429,1.0,1.0,10/11,58.16%,ITCH;CXCL9;CXCL2;CXCL13;PPBP;PF4;CXCL1;CXCL5;YARS1;CXCL10
prerank,solute:proton symporter activity (GO:0015295),0.2333411797796058,0.4782552986495774,0.9642365887207703,1.0,1.0,5/16,23.21%,SLC39A8;SLC15A4;SLC15A1;SLC17A5;SLC11A2
prerank,kinase inhibitor activity (GO:0019210),0.21468348514378416,0.4766528142224851,0.9823321554770318,1.0,1.0,7/33,20.67%,PARVA;NCK1;CDKN1B;QARS1;SH3BP5;TRIB1;SNCA
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.22359296457435474,0.47524759608688594,0.9654320987654321,1.0,1.0,5/25,16.05%,SESTD1;ZFYVE1;MAPKAP1;PLEKHA1;DAPP1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.21907625739734177,0.4749935247728561,0.9765319426336375,1.0,1.0,1/21,5.79%,FRS2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.2526831105253249,0.47329820857358323,0.9640179910044977,1.0,1.0,10/10,74.75%,ANKRD13D;DNAJB2;DNAJC2;IDE;ANKRD13A;USP15;FAN1;FAAP20;LAPTM5;ANKRD13B
prerank,peptidase inhibitor activity (GO:0030414),0.21185378482737524,0.47262309303828,0.9810201660735468,1.0,1.0,9/33,24.05%,CAST;SIMC1;USP14;PROS1;TFPI;RECK;PSMF1;GPC3;ITIH2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.1975948918387811,0.46782666650090016,0.9916926272066459,1.0,1.0,4/75,5.89%,PTGR1;RDH11;SORD;RDH12
prerank,carbohydrate kinase activity (GO:0019200),-0.1824629676123525,-0.464678258209709,0.9903225806451613,1.0,1.0,11/11,81.77%,HK1;NAGK;POMK;XYLB;KHK;HK3;GALK1;HK2;GNE;FGGY;GALK2
prerank,solute:anion antiporter activity (GO:0140323),0.22511796213397092,0.463568586535814,0.9680232558139535,1.0,1.0,1/14,8.21%,SLC4A2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.17094074040802332,-0.46221923804797405,0.9933110367892977,1.0,1.0,13/15,54.44%,SLC4A8;SLC26A2;SLC26A6;CFTR;SLC26A8;SLC4A11;SLC26A4;SLC4A3;SLC26A7;SLC26A3;SLC4A1;SLC26A5;SLC26A1
prerank,receptor antagonist activity (GO:0048019),0.2215245510485998,0.460046574678163,0.9777195281782438,1.0,1.0,17/17,77.87%,DKK3;LRPAP1;PXDN;DKK4;IL1RN;DKK1;ADH7;WFIKKN2;DKKL1;AGTR2;FST;WFIKKN1;IGSF1;CCL5;ESR2;IL18BP;DKK2
prerank,cAMP response element binding (GO:0035497),0.23957077375169822,0.4552999816948279,0.9768518518518519,1.0,1.0,4/10,24.22%,CREB5;CREB3L2;ATF7;ATF2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.20520627406800063,0.446115807687229,0.9762470308788599,1.0,1.0,3/32,9.09%,FTO;KDM2B;HSPBAP1
prerank,chemokine receptor activity (GO:0004950),0.2043795172199917,0.4460701665615419,0.988997555012225,1.0,1.0,1/24,6.31%,CXCR4
prerank,CCR chemokine receptor binding (GO:0048020),-0.13415017279296262,-0.4438200368550341,1.0,0.997021881776451,1.0,28/28,86.61%,CX3CL1;NARS1;CCL13;CCL19;CCL15;CCR2;CCL2;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13;CCL22;CCL17;CCL24;CCL26;CCL25;CCL14;CNIH4;NES
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.2212090931881946,0.43267246980885343,0.9940209267563528,1.0,1.0,4/10,23.30%,DSE;GLCE;DSEL;GNE
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.1837778310511987,0.43113510119138465,0.9968354430379747,1.0,1.0,6/73,12.22%,GALR1;BDKRB2;NPR3;S1PR2;NLRP6;GLP2R
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.2165217112277649,0.4272540959663732,0.980309423347398,1.0,1.0,4/14,22.61%,CIAO3;ACO1;ISCA2;SDHB
prerank,retinoid X receptor binding (GO:0046965),0.2189730213204729,0.4224576833383762,0.9824046920821115,0.9989350274718427,1.0,3/11,20.22%,NR4A2;ARID5A;MED25
prerank,telomerase RNA binding (GO:0070034),0.1943212076273563,0.40832290231779694,0.9848101265822785,0.9992946032982891,1.0,6/22,19.78%,HNRNPU;SMG6;TEP1;EXOSC10;TERT;SNRPB
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.20523517769879235,0.40617108401520235,0.9882525697503671,0.9975215942109945,1.0,4/11,23.31%,NAA20;NAA60;NAA40;NAA50
prerank,cytokine receptor activity (GO:0004896),0.1699315268365714,0.3960887123046544,1.0,0.9968202257525846,1.0,2/83,5.85%,IL1RL1;LEPR
prerank,gated channel activity (GO:0022836),0.17331947187306954,0.3470000759068399,0.997134670487106,0.998724870847633,1.0,3/14,20.23%,PIEZO1;TMEM63A;PIEZO2
